Questionnaire Outline: Steglujan 2021 Consumer Tracking 201705 December 03, 2021

LRW Study Name: Steglujan 2021 Consumer Tracking
LRW Job Number: 201705

Date: December 03, 2021
The contents of this document are the confidential property of Lieberman Research Worldwide. No part of this document may be
reproduced or distributed in any form without the express written permission of Lieberman Research Worldwide.
QUESTIONNAIRE OUTLINE
Hold CTRL and click on a question to jump there

Screener.......................................................................................................................................................................................................................4
DV_LinkType.........................................................................................................................................................................................................4
DV_Week..............................................................................................................................................................................................................5
DV_WeekofMonth.................................................................................................................................................................................................6
DV_Wave..............................................................................................................................................................................................................7
DV_Month.............................................................................................................................................................................................................7
DV_Year................................................................................................................................................................................................................7
DV_Quarter...........................................................................................................................................................................................................8
DT_Intro................................................................................................................................................................................................................8
S1a_ContinueSurvey............................................................................................................................................................................................8
S1_SensitiveIndustry............................................................................................................................................................................................8
S2_Gender............................................................................................................................................................................................................9
S3_YearBorn.........................................................................................................................................................................................................9
DV_Age.................................................................................................................................................................................................................9
DV_AgeRange......................................................................................................................................................................................................9
DV_AgeGender.....................................................................................................................................................................................................9
S4_Zip.................................................................................................................................................................................................................10
DV_Region..........................................................................................................................................................................................................10
DV_TargetMarketDMA........................................................................................................................................................................................10
DV_TargetDMAVsNational.................................................................................................................................................................................10
DV_State.............................................................................................................................................................................................................11
DV_ReactivityTierMar20.....................................................................................................................................................................................11
S5_Hispanic........................................................................................................................................................................................................12
S6_Ethnicity........................................................................................................................................................................................................12
DV_EthnicityNet..................................................................................................................................................................................................12
DV_AfricanAmerican...........................................................................................................................................................................................12
S7_HealthConditions..........................................................................................................................................................................................13
S8_CurrentTreatments.......................................................................................................................................................................................13
S9_BrandUnaidedAwareness.............................................................................................................................................................................14
DV_Brand_TopOfMind........................................................................................................................................................................................14
S10_OralMed_Usage.........................................................................................................................................................................................15
S11_Injections_Usage........................................................................................................................................................................................16
DV_BrandsAware...............................................................................................................................................................................................17
DV_BrandsFamiliar.............................................................................................................................................................................................18
DV_CurrentMedUsage........................................................................................................................................................................................19
DV_MedClass_Usage.........................................................................................................................................................................................20
DV_SteglujanFranUser.......................................................................................................................................................................................20
DV_PastUsage...................................................................................................................................................................................................20
DV_Total_FamCount..........................................................................................................................................................................................21
Subsection Start - Segmentation Measures...........................................................................................................................................................21
DT_Steg_Segmentation......................................................................................................................................................................................21
S12_SegmentQ1................................................................................................................................................................................................21
S13_SegmentQ2................................................................................................................................................................................................21
S14_SegmentQ3................................................................................................................................................................................................22
S15_SegmentQ4................................................................................................................................................................................................22
DV_Steg_Segment.............................................................................................................................................................................................22
S16_AttentiveBipolar..........................................................................................................................................................................................23
Treatment Brand Funnel............................................................................................................................................................................................24
DV_Brands_Eligible............................................................................................................................................................................................24
DV_Brands_Assigned.........................................................................................................................................................................................24
DT_A_Intro..........................................................................................................................................................................................................24
A1_BrandAwareSource......................................................................................................................................................................................25
A12_FirstBrandAware.........................................................................................................................................................................................26
Loop Start - BrandRatings......................................................................................................................................................................................27
A2_TreatmentPerformance................................................................................................................................................................................28
A3_Usage_Duration............................................................................................................................................................................................29
DV_MedClass_Duration.....................................................................................................................................................................................30
DV_Steglujan_Duration......................................................................................................................................................................................30
A4_UseSamples.................................................................................................................................................................................................31
A5_MedSatisfaction............................................................................................................................................................................................31
LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 1

Loop Start - ReasonsSwitch...................................................................................................................................................................................31
A6_ReasonSwitchOffSteg..................................................................................................................................................................................32
A7_ConsiderAskingDr.........................................................................................................................................................................................33
Loop Start - BrandConsiderations..........................................................................................................................................................................33
A8_ReasonsToConsider.....................................................................................................................................................................................34
A9_ReasonsNotConsider...................................................................................................................................................................................34
A10_ConsiderSwitching......................................................................................................................................................................................35
A11_OpenToAddingMed....................................................................................................................................................................................35
Communications.........................................................................................................................................................................................................36
DT_B_Intro..........................................................................................................................................................................................................36
B1_Ad_UnaidedAwareness................................................................................................................................................................................36
DV_TopOfMindAd...............................................................................................................................................................................................36
B2_Ad_AidedAwareness....................................................................................................................................................................................37
B3_AdAwarenessSources..................................................................................................................................................................................37
B4_SocialMediaAware........................................................................................................................................................................................38
B5_DocOfficeAdAware.......................................................................................................................................................................................39
Loop Start - AdMessageRecall...............................................................................................................................................................................39
B6_Ad_MessageRecall.......................................................................................................................................................................................40
DT_Ad_Intro........................................................................................................................................................................................................40
DV_AdsEligibile..................................................................................................................................................................................................41
DV_AdsAssigned................................................................................................................................................................................................41
Loop Start - AdRecall_Diagnostics.........................................................................................................................................................................41
B7_P3M_AdAware..............................................................................................................................................................................................42
B8_AdFrequency................................................................................................................................................................................................43
B9_AdEmotion....................................................................................................................................................................................................43
B10_AdBrandAssociation...................................................................................................................................................................................43
DV_AdBrand_ID.................................................................................................................................................................................................44
DV_InsertBrandName.........................................................................................................................................................................................44
B11_AdEvaluation..............................................................................................................................................................................................45
B12_ActionTakenBranded..................................................................................................................................................................................46
B20_MethodHCPSpoke......................................................................................................................................................................................46
B13_WebSearch.................................................................................................................................................................................................46
B14_DiscussedBrand.........................................................................................................................................................................................47
B15_PrescribeInstead.........................................................................................................................................................................................47
DV_B16QuestionText.........................................................................................................................................................................................48
B16_LikelihoodTalkDoctor..................................................................................................................................................................................48
DV_P3MAdAware...............................................................................................................................................................................................48
DT_UnbrandedAd_Intro......................................................................................................................................................................................49
DV_UnbrandedAdEligible...................................................................................................................................................................................49
DV_UnbrandedAdAssigned................................................................................................................................................................................49
Loop Start - UnbrandedAdRecall_Diagnostics.......................................................................................................................................................49
B17_P3M_UnbrandedAdAware..........................................................................................................................................................................50
B18_UnbrandedAdClick......................................................................................................................................................................................50
B19_UnbrandedAssociation...............................................................................................................................................................................51
DV_UnbrandedAd_ID.........................................................................................................................................................................................51
DV_P3MUnbrandedAdAware.............................................................................................................................................................................51
Digital IQ.....................................................................................................................................................................................................................52
DT_DigitalIQ_Intro..............................................................................................................................................................................................52
C1_DigitalActivity................................................................................................................................................................................................52
C2_Activites........................................................................................................................................................................................................52
C3_SocialMediaPlatforms..................................................................................................................................................................................52
C4_AccessingInternet.........................................................................................................................................................................................52
C5_TabletUse.....................................................................................................................................................................................................53
C6_SmartphoneSkill...........................................................................................................................................................................................53
C7_KnowHowTo.................................................................................................................................................................................................53
C8_CloudConfidence..........................................................................................................................................................................................53
C9_PersonalInformation.....................................................................................................................................................................................54
C10_TechBipolar................................................................................................................................................................................................54
DV_DigitalIQSegments.......................................................................................................................................................................................54
Demographics............................................................................................................................................................................................................55
DT_DemoIntro....................................................................................................................................................................................................55
D1_TypesOfInsurance........................................................................................................................................................................................55
D2_MedCoverage...............................................................................................................................................................................................55
D3_PhysicianType..............................................................................................................................................................................................55
D4_FillPrescriptions............................................................................................................................................................................................55
DV_Num_MedsUsage........................................................................................................................................................................................56
D5_NumPrescriptions.........................................................................................................................................................................................56
D6_MedConvenience.........................................................................................................................................................................................56
D7_AgeDiagnosed..............................................................................................................................................................................................56
DV_AgeDiagnosedDifference.............................................................................................................................................................................56
D8_ActivityFrequency.........................................................................................................................................................................................57
D9_GroceryNum.................................................................................................................................................................................................57
D10_GroceryTransport.......................................................................................................................................................................................57
D11_Income........................................................................................................................................................................................................57
DV_IncomeNets..................................................................................................................................................................................................57
D12_Education...................................................................................................................................................................................................58
D13_HispanicOrigin............................................................................................................................................................................................58
D14_HHSize.......................................................................................................................................................................................................58
D15_Children......................................................................................................................................................................................................58
D16_NumChildren..............................................................................................................................................................................................59
Subsection Start - COVID-19 Custom Section.......................................................................................................................................................59
D22_MedBehaviorChange.................................................................................................................................................................................59
D23_PharmaHomeDelivery................................................................................................................................................................................59
D24_LikelihoodToSwitch....................................................................................................................................................................................59
D25_ChangeToMedCare....................................................................................................................................................................................60
Subsection Start - COVID-19 Behavior Module.....................................................................................................................................................60
DT_COVIntro......................................................................................................................................................................................................60
D17_BehaviorChange.........................................................................................................................................................................................60
D19_ActivityChanges..........................................................................................................................................................................................60
D20_BehaviorResume........................................................................................................................................................................................61
D21_COVIncomeChange...................................................................................................................................................................................61
QC Flags....................................................................................................................................................................................................................62

SCREENER
- Programmer: Please only allow these devices into the survey: PC, Tablet, Smartphone.
[DV_LinkType]
- Hidden Question. Applies to all.
- Programmer Comment: Suppress 2021 - Will not be using separate links 2021 onward.
DV_LinkType Hidden variable to capture if coming from Target Market Link or Other Market Link
.
Select one response.
DEFAULT ORDER.
1. Target Market Link
2. Other Market Link

[DV_Week]
DV_Week. Capture week based on current date for continuous tracking.
DEFAULT ORDER.
1. Week 1 Jan 5-Jan 11, 2020
2. Week 2 Jan 12-Jan 18, 2020
3. Week 3 Jan 19-Jan 25, 2020
4. Week 4 Jan 26-Feb 1, 2020
5. Week 5 Feb 2-Feb 8, 2020
6. Week 6 Feb 9-Feb 15, 2020
7. Week 7 Feb 16-Feb 22, 2020
8. Week 8 Feb 23-Feb 29, 2020
9. Week 9 Mar 1-Mar 7, 2020
10. Week 10 Mar 8-Mar 14, 2020
11. Week 11 Mar 15-Mar 21, 2020
12. Week 12 Mar 22-Mar 28, 2020
13. Week 13 Mar 29-Apr 4, 2020
14. Week 14 Apr 5-Apr 11, 2020
15. Week 15 Apr 12-Apr 18, 2020
16. Week 16 Apr 19-Apr 25, 2020
17. Week 17 Apr 26-May 2, 2020
18. Week 18 May 3-May 9, 2020
19. Week 19 May 10-May 16, 2020
20. Week 20 May 17-May 23, 2020
21. Week 21 May 24-May 30, 2020
22. Week 22 May 31-Jun 6, 2020
23. Week 23 Jun 7-Jun 13, 2020
24. Week 24 Jun 14-Jun 20, 2020
25. Week 25 Jun 21-Jun 27, 2020
26. Week 26 Jun 28-Jul 4, 2020
27. Week 27 Jul 5-Jul 11, 2020
28. Week 28 Jul 12-Jul 18, 2020
29. Week 29 Jul 19-Jul 25, 2020
30. Week 30 Jul 26-Aug 1, 2020
31. Week 31 Aug 2-Aug 8, 2020
32. Week 32 Aug 9-Aug 15, 2020
33. Week 33 Aug 16-Aug 22, 2020
34. Week 34 Aug 23-Aug 29, 2020
35. Week 35 Aug 30-Sep 5, 2020
36. Week 36 Sep 6-Sep 12, 2020
37. Week 37 Sep 13-Sep 19, 2020
38. Week 38 Sep 20-Sep 26, 2020
39. Week 39 Sep 27-Oct 3, 2020
40. Week 40 Oct 4-Oct 10, 2020
41. Week 41 Oct 11-Oct 17, 2020
42. Week 42 Oct 18-Oct 24, 2020
43. Week 43 Oct 25-Oct 31, 2020
44. Week 44 Nov 1-Nov 7, 2020
45. Week 45 Nov 8-Nov 14, 2020
46. Week 46 Nov 15-Nov 21, 2020
47. Week 47 Nov 22-Nov 28, 2020
48. Week 48 Nov 29-Dec 5, 2020
49. Week 49 Dec 6-Dec 12, 2020
50. Week 50 Dec 13-Dec 19, 2020
51. Week 51 Dec 20-Dec 26, 2020
52. Week 52 Dec 27-Jan 2, 2021
53. Week 53 Jan 3-Jan 9, 2021
54. Week 54 Jan 10-Jan 16, 2021
55. Week 55 Jan 17-Jan 23, 2021
56. Week 56 Jan 24-Jan 30, 2021
57. Week 57 Jan 31-Feb 6, 2021
58. Week 58 Feb 7-Feb 13, 2021
59. Week 59 Feb 14-Feb 20, 2021
60. Week 60 Feb 21-Feb 27, 2021
61. Week 61 Feb 28-Mar 6, 2021
62. Week 62 Mar 7-Mar 13, 2021
63. Week 63 Mar 14-Mar 20, 2021
64. Week 64 Mar 21-Mar 27, 2021
65. Week 65 Mar 28-Apr 3, 2021
66. Week 66 Apr 4-Apr 10, 2021
67. Week 67 Apr 11-Apr 17, 2021
68. Week 68 Apr 18-Apr 24, 2021
69. Week 69 Apr 25-May 1, 2021
70. Week 70 May 2-May 8, 2021
71. Week 71 May 9-May 15, 2021
72. Week 72 May 16-May 22, 2021
73. Week 73 May 23-May 29, 2021
74. Week 74 May 30-Jun 5, 2021
75. Week 75 Jun 6-Jun 12, 2021
76. Week 76 Jun 13-Jun 19, 2021
77. Week 77 Jun 20-Jun 26, 2021
78. Week 78 Jun 27-Jul 3, 2021
79. Week 79 Jul 4-Jul 10, 2021
80. Week 80 Jul 11-Jul 17, 2021
81. Week 81 Jul 18-Jul 24, 2021
82. Week 82 Jul 25-Jul 31, 2021
83. Week 83 Aug 1-Aug 7, 2021
84. Week 84 Aug 8-Aug 14, 2021
85. Week 85 Aug 15-Aug 21, 2021
86. Week 86 Aug 22-Aug 28, 2021
87. Week 87 Aug 29-Sep 4, 2021
88. Week 88 Sep 5-Sep 11, 2021
89. Week 89 Sep 12-Sep 18, 2021
90. Week 90 Sep 19-Sep 25, 2021
91. Week 91 Sep 26-Oct 2, 2021
92. Week 92 Oct 3-Oct 9, 2021
93. Week 93 Oct 10-Oct 16, 2021
94. Week 94 Oct 17-Oct 23, 2021
95. Week 95 Oct 24-Oct 30, 2021
96. Week 96 Oct 31-Nov 6, 2021
97. Week 97 Nov 7-Nov 13, 2021
98. Week 98 Nov 14-Nov 20, 2021
99. Week 99 Nov 21-Nov 27, 2021
100. Week 100 Nov 28-Dec 4, 2021
101. Week 101 Dec 5-Dec 11, 2021
102. Week 102 Dec 12-Dec 18, 2021
103. Week 103 Dec 19-Dec 25, 2021
104. Week 104 Dec 26-Jan 1, 2021
[DV_WeekofMonth]
DV_WeekofMonth. Capture generic week of the month
DEFAULT ORDER.
1. Week 1 (Day 1 - 7) PC: Autopunch for Day 1 - 7 of the month
2. Week 2 (Day 8-14) PC: Autopunch for Day 8 - 14 of the month
5. Week 5 (Day 29 -31) PC: Autopunch for Day 29 - 31 of the month

[DV_Wave]
DV_Wave. Code for wave based on current date for continuous tracking.
DEFAULT ORDER.
1. Wave 1: January 2020
2. Wave 2: February 2020
3. Wave 3: March 2020
4. Wave 4: April 2020
5. Wave 5: May 2020
6. Wave 6: June 2020
7. Wave 7: July 2020
8. Wave 8: August 2020
9. Wave 9: September 2020
10. Wave 10: October 2020
11. Wave 11: November 2020
12. Wave 12: December 2020
15. Wave 15: March 2021
16. Wave 16: April 2021
17. Wave 17: May 2021
18. Wave 18: June 2021
19. Wave 19: July 2021
27. Wave 27: March 2022
28. Wave 28: April 2022
29. Wave 29: May 2022
30. Wave 30: June 2022
31. Wave 31: July 2022
[DV_Month]
DV_Month. Capture current month for continuous tracking.
DEFAULT ORDER.
1. January
2. February
3. March
4. April
5. May
6. June
7. July
8. August
9. September
10. October
11. November
12. December
[DV_Year]
DV_Year. Capture current year of tracker
DEFAULT ORDER.
1. 2020
2. 2021
3. 2022

[DV_Quarter]
DV_Quarter. Code based on current date and waves completed
DEFAULT ORDER.
1. Q1: Jan - Mar Autocode if respondent selected any codes [1-3]
at DV_Month.
2. Q2: Apr - Jun Autocode if respondent selected any codes [4-6]
at DV_Month.
3. Q3: Jul - Sep Autocode if respondent selected any codes [7-9]
at DV_Month.
4. Q4: Oct - Dec Autocode if respondent selected any codes [10-
12] at DV_Month.
[Intro]
- Show to all.
DT_Intro. We appreciate your interest in our confidential survey. This survey should take approximately 20 minutes.
Please do not use your browser's forward and back buttons. Instead use the 'Next' button to move through the survey.
[ContinueSurvey]
- Show to all.
- Terminate Immediately if respondent selected code [3] at S1a_ContinueSurvey.
S1a_ContinueSurvey. Different patients may respond in different ways to the same medicine or healthcare product and some side effects
or unfavorable reactions may not be discovered until many people have used the medicine or healthcare product.
For this reason, we are now required to pass on to our client, the sponsoring company, details of any side effects,
unfavorable reactions or any Product Quality Complaints related to their own products that are mentioned during the
course of market research.
Information on side effects, unfavorable reactions or Product Quality Complaints provided by you may be shared
with regulatory agencies, the sponsoring company's subsidiaries worldwide, and business partners with whom the
sponsoring company has contractual agreements. Any information that identifies the patient directly, such as the
patient's initials or date of birth, will be handled confidentially.
DEFAULT ORDER.
1. I would like to proceed and give permission for my
contact details to be passed on to the Drug Safety
department of the company if an adverse event/ product
complaint is mentioned by me during the survey
2. I would like to proceed but do not wish for my contact
details to be passed on to the Drug Safety department of
the company if an adverse event/ product complaint is
mentioned by me during the survey
3. I don’t want to proceed and wish to end the interview here Terminate immediately.
[SensitiveIndustry]
- Show to all.
- Terminate Immediately if respondent selected any codes [1-4] at S1_SensitiveIndustry.
S1_SensitiveIndustry. Are you, or any member of your household, currently employed by any of the following?
Select all that apply.
RANDOMIZE LIST.
1. A public relations or advertising agency Terminate immediately.
2. A marketing or marketing research company Terminate immediately.
3. A company that makes or distributes pharmaceutical Terminate immediately.
products
4. A hospital, medical clinic, doctor's office or any other job Terminate immediately.
in the medical field
5. A furniture company
6. A banking or financial services company
99. None of the above ANCHOR. EXCLUSIVE.

[Gender]
- Show to all.
S2_Gender. Please select your gender.
DEFAULT ORDER.
1. Male
2. Female
[YearBorn]
- Show to all.
S3_YearBorn. In what year were you born?
Enter a numeric response.
MIN: 1915. MAX: 2020. INTEGER NUMERIC RESPONSES.
[DV_Age]
- Terminate Immediately if value provided at DV_Age is NOT between 34 and 76.
- Programmer Comment: Calculate age based on current year.
DV_Age. Hidden variable to capture age based on YearBorn
[DV_AgeRange]
DV_AgeRange. Hidden variable to capture age ranges.
DEFAULT ORDER.
1. 35-44 Autocode if value provided at DV_Age is between
(inclusive) 35 and 44.
[DV_AgeGender]
DV_AgeGender. Hidden Variable to capture nested age and gender.
DEFAULT ORDER.
1. Male 35-44 Autocode if respondent selected code [1] at
S2_Gender AND respondent selected code [1] at
DV_AgeRange.
DV_AgeRange.
DV_AgeRange.
4. Male 65+ Autocode if respondent selected code [1] at
DV_AgeRange.
5. Female 35-44 Autocode if respondent selected code [2] at
DV_AgeRange.
DV_AgeRange.
DV_AgeRange.
8. Female 65+ Autocode if respondent selected code [2] at
DV_AgeRange.

[Zip]
- Show to all.
- Programmer Comment: Allow up to 3 tries. Else, hard term.
S4_Zip. What is your zip code?
MIN: 5. MAX: 5.
[DV_Region]
DV_Region. Hidden variable to capture Region based on zip
DEFAULT ORDER.
1. Midwest
2. Northeast
3. South
4. West
[DV_TargetMarketDMA]
- Terminate Immediately if respondent selected code [1] at DV_LinkType AND respondent selected code [7] at
DV_TargetMarketDMA.
- Programmer Comment: We are using standard DMA database here.
DV_TargetMarketDMA. Captures if respondent is coming from a target market based on zipcode.
DEFAULT ORDER.
1. Pittsburgh, PA - 508 PC: Autocode if zip code at S4_Zip matches
Pittsburgh DMA
2. Memphis, TN - 640 PC: Autocode if zip code at S4_Zip matches
Memphis DMA
3. Jacksonville, FL - 561 PC: Autocode if zip code at S4_Zip matches
Jacksonville DMA
4. El Paso, TX - 765 PC: Autocode if zip code at S4_Zip matches El
Paso DMA
5. Raleigh, NC - 560 PC: Autocode if zip code at S4_Zip matches
Raleigh DMA
6. Greenville - Spartanburg, SC/Asheville, NC - 567 PC: Autocode if zip code at S4_Zip matches
Greenville - Spartansburg / Asheville DMA
7. Other Markets - Not Target Autocode if respondent did NOT select codes [1-6]
at DV_TargetMarketDMA.
[DV_TargetDMAVsNational]
DV_TargetDMAVsNational. Capture if coming from target markets or other markets
DEFAULT ORDER.
1. Target DMA Market Autocode if respondent selected any codes [1-6]
at DV_TargetMarketDMA.
2. National Markets Autocode if respondent selected code [7] at
DV_TargetMarketDMA.

[DV_State]
DV_State. Automark state based on ZIP
DEFAULT ORDER.
1. Alabama
2. Alaska
3. Arizona
4. Arkansas
5. California
6. Colorado
7. Connecticut
8. Delaware
9. Florida
10. Georgia
11. Hawaii
12. Idaho
13. Illinois
14. Indiana
15. Iowa
16. Kansas
17. Kentucky
18. Louisiana
19. Maine
20. Maryland
21. Massachusetts
22. Michigan
23. Minnesota
24. Mississippi
25. Missouri
26. Montana
27. Nebraska
28. Nevada
29. New Hampshire
30. New Jersey
31. New Mexico
32. New York
33. North Carolina
34. North Dakota
35. Ohio
36. Oklahoma
37. Oregon
38. Pennsylvania
39. Rhode Island
40. South Carolina
41. South Dakota
42. Tennessee
43. Texas
44. Utah
45. Vermont
46. Virginia
47. Washington
48. Washington D.C.
49. West Virginia
50. Wisconsin
51. Wyoming
[DV_ReactivityTierMar20]
- Note to client: DV for tracking reactivity for each state as of 3/20/2020. Highly recommend addition to all US studies.
DV_ReactivityTierMar20. DV to track reactivity of each US state to COVID-19, based on 3/20/2020 reports.
DEFAULT ORDER.
1. Most reactive states Autocode if respondent selected any codes [2, 5,
7, 9, 11, 19, 28, 30, 32, 37, 39, 44, 47-48] at
DV_State.
2. Least reactive states Autocode if respondent selected any codes [12,
26, 34, 36, 41, 49] at DV_State.
3. Moderate reactive states Autocode if respondent did NOT select codes [1-2]
at DV_ReactivityTierMar20.

[Hispanic]
- Show to all.
S5_Hispanic. Are you of Hispanic or Latino origin?
DEFAULT ORDER.
1. Yes
2. No
[Ethnicity]
- Show if respondent selected code [2] at S5_Hispanic.
S6_Ethnicity. Which categories describe your race?
DEFAULT ORDER.
1. Caucasian or White
2. African-American or Black
3. Asian or Pacific Islander
97. Other
98. Prefer not to say EXCLUSIVE.
[DV_EthnicityNet]
DV_EthnicityNet. Hidden variable to capture Ethnicity Net for weighting/quota.
DEFAULT ORDER.
1. Caucasian or White Autocode if respondent selected exactly code [1]
at S6_Ethnicity.
2. Hispanic Autocode if respondent selected code [1] at
S5_Hispanic.
3. African-American or Black Autocode if respondent selected exactly code [2]
at S6_Ethnicity.
4. Asian or Pacific Islander Autocode if respondent selected exactly code [3]
at S6_Ethnicity.
5. Other Autocode if respondent did NOT select codes [1-4]
at DV_EthnicityNet.
[DV_AfricanAmerican]
DV_AfricanAmerican. DV to Capture if respondent is African American or Not
DEFAULT ORDER.
1. African American Autocode if respondent selected code [3] at
DV_EthnicityNet.
2. Not African American Autocode if respondent did NOT select code [3] at
DV_EthnicityNet.

[HealthConditions]
- Show to all.
- Terminate Immediately if respondent selected any codes [4, 98-99] at S7_HealthConditions OR respondent did NOT select code [3]
at S7_HealthConditions OR respondent selected all codes [1-3, 5-13] at S7_HealthConditions OR respondent selected all codes [14-
15] at S7_HealthConditions.
S7_HealthConditions. Next, we would like to ask you several questions about your health.
Which of the following health conditions, if any, have you been diagnosed with by a physician or healthcare
professional?
RANDOMIZE LIST.
1. High cholesterol
2. High blood pressure
ALPHABETICAL ORDER.
3. Type 2 diabetes (adult onset diabetes)
4. Type 1 diabetes (juvenile onset diabetes) Terminate immediately.
5. Gestational diabetes (during pregnancy only)
6. Arthritis/Osteoarthritis
7. COPD (chronic obstructive pulmonary disease)
8. Depression
9. Acid reflux (heartburn)
10. Migraine headaches
11. Cardiovascular or heart disease
12. Obesity
13. Chronic kidney disease
14. Short bowel syndrome
15. Gaucher disease
99. None of these ANCHOR. EXCLUSIVE. Terminate immediately.
98. Prefer not to answer ANCHOR. EXCLUSIVE. Terminate immediately.
[CurrentTreatments]
- Show to all.
- Terminate Immediately if respondent did NOT select code [1] at S8_CurrentTreatments.
S8_CurrentTreatments. Which of the following treatments are you currently using to manage your Type 2 Diabetes?
RANDOMIZE LIST.
1. Oral prescription medication
2. Insulin
3. Injectable prescription medication (other than insulin)
4. Treatments that are not prescription medications (such as
vitamins, herbal remedies, etc.)
5. Diet
6. Exercise
99. None of these ANCHOR. EXCLUSIVE.

[BrandUnaidedAwareness]
- Show to all.
- Programmer Comment: Don't allow respondents to skip boxes.
Capture first mention as DV_Brand_TopOfMind.
Error message if respondent skips a box: Please make sure no boxes are skipped in your response(s).
Error Message if respondent types under 3 characters: Please check your response(s) and ensure they are fully spelled out.
Error message if respondent tries to skip question without filling out any boxes and not clicking opt-out box: Please select "I can't
think of any" if you cannot think of any medications.
if needed example function can be found here: \\cnc-fsh-106p.elrw.com\Projects2019\006_IPS\Questions - Code and

Templates\Custom Functions\FUNCTION_Text grid validation with opt out and correct order of boxes filled out.txt
Question previously programmed - referencing the 181148 study: https://apps.lrwonline.com/WebAuthor/#/questionnaire/5639/
S9_BrandUnaidedAwareness. What prescription medications for Type 2 Diabetes are you aware of?
Enter your response(s) in the box(es). Please type in all medications for this condition that come to mind,
even if you've just heard of the name.
COLS: DEFAULT ORDER.

ROWS: DEFAULT ORDER.
1. 1 [] PC: Record as TOM
2. 2 []
3. 3 []
4. 4 []
5. 5 []
6. 6 []
7. 7 []
8. 8 []
99. I can't think of any [] ANCHOR. EXCLUSIVE. PC: Opt out option
MIN: 3. MAX:
200.
[DV_Brand_TopOfMind]
DV_Brand_TopOfMind. Captures first mention from S9.
Enter your response in the box.
MIN: 3. MAX: 200.

[OralMed_Usage]
- Show to all.
- Terminate Immediately if, for every row [25-26] at S10_OralMed_Usage, the respondent selected any codes [2-5].
- Programmer Comment: Term immediately if column code 1 ("Never heard of it") is selected for EVERY row shown (i.e., if
respondent has never heard of any brands shown)
S10_OralMed_Usage. Even though you may have mentioned some of these medications earlier, please indicate your level of awareness
or experience with the following oral prescription medications for Type 2 Diabetes.
Select one response for each.
Heard the Have used

name, but I know a it in the
COLS: DEFAULT ORDER. don’t know lot about it, past, but
ROWS: ALPHABETICAL Never anything but don’t no longer I currently
ORDER. heard of it about it use it use it use it
1. Steglujan (ertugliflozin +
1 2 3 4 5
sitagliptin)
2. Steglatro (ertugliflozin) 1 2 3 4 5
3. Rybelsus (semaglutide) 1 2 3 4 5
4. Jardiance
1 2 3 4 5
(empagliflozin)
5. Farxiga (dapagliflozin) 1 2 3 4 5
7. Glyxambi (empagliflozin
1 2 3 4 5
+ linagliptin)
8. Invokamet (canagliflozin
1 2 3 4 5
+ metformin)
9. Invokana (canagliflozin) 1 2 3 4 5
10. Janumet (sitagliptin +
1 2 3 4 5
metformin)
11. Janumet XR
1 2 3 4 5
(sitagliptin + metformin)
12. Januvia (sitagliptin) 1 2 3 4 5
13. Jentadueto (linagliptin
1 2 3 4 5
+ metformin)
14. Kombiglyze XR
1 2 3 4 5
(saxagliptin + metformin)
15. Qtern (dapagliflozin +
1 2 3 4 5
saxagliptin)
16. Segluromet
(ertugliflozin + metformin 1 2 3 4 5
hydrochloride)
17. Synjardy
(empagliflozin + 1 2 3 4 5
metformin)
18. Xigduo (dapagliflozin +
1 2 3 4 5
metformin)
19. Tradjenta (linagliptin) 1 2 3 4 5
24. Trijardy XR
(empagliflozin + linagliptin 1 2 3 4 5
+ metformin hydrochloride)
25. Gapinovka
1 2 3 4 5
(hydrochlorixin)
26. Vivandien (gaphormin) 1 2 3 4 5

[Injections_Usage]
- Show to all.
- Terminate Immediately if, for every row [27-28] at S11_Injections_Usage, the respondent selected any codes [2-5].
S11_Injections_Usage. And just like before, please indicate your level of awareness or experience with the following injectable prescription
medications for Type 2 Diabetes.
Heard the Have used

name, but I know a it in the
COLS: DEFAULT ORDER. don’t know lot about it, past, but
ROWS: ALPHABETICAL Never anything but don’t no longer I currently
ORDER. heard of it about it use it use it use it
6. Ozempic (semaglutide) 1 2 3 4 5
20. Toujeo (insulin
1 2 3 4 5
glargine)
21. Tresiba (insulin
1 2 3 4 5
degludec)
22. Trulicity (dulaglutide) 1 2 3 4 5
23. Victoza (liraglutide) 1 2 3 4 5
27. Apoflorixia (gertudide) 1 2 3 4 5
28. Comuglasibe
1 2 3 4 5
(uglasitin)

[DV_BrandsAware]
- Hidden Question. Applies to all. Autocode row stubs selected at any of these column(s) [2-5] at S10_OralMed_Usage OR selected
at any of these column(s) [2-5] at S11_Injections_Usage.
- Programmer Comment: Autocode row stubs selected at S10_OralMed_Usage OR selected at S11_Injections_Usage for columns
[HeardTheName, IKnowA, HaveUsedIt, ICurrentlyUse]
DV_BrandsAware. AIDED BRAND AWARENESS. Capture all brands aware of from S10 & S11
DEFAULT ORDER.
1. Steglujan (ertugliflozin + sitagliptin) Autocode if, for any row [1] at
S10_OralMed_Usage, the respondent selected any
codes [2-5].
2. Steglatro (ertugliflozin) Autocode if, for any row [2] at
codes [2-5].
3. Rybelsus (semaglutide) Autocode if, for any row [3] at
codes [2-5].
4. Jardiance (empagliflozin) Autocode if, for any row [4] at
codes [2-5].
5. Farxiga (dapagliflozin) Autocode if, for any row [5] at
codes [2-5].
6. Ozempic (semaglutide) Autocode if, for any row [6] at
S11_Injections_Usage, the respondent selected
any codes [2-5].
7. Glyxambi (empagliflozin + linagliptin) Autocode if, for any row [7] at
codes [2-5].
8. Invokamet (canagliflozin + metformin) Autocode if, for any row [8] at
codes [2-5].
9. Invokana (canagliflozin) Autocode if, for any row [9] at
codes [2-5].
10. Janumet (sitagliptin + metformin) Autocode if, for any row [10] at
codes [2-5].
11. Janumet XR (sitagliptin + metformin) Autocode if, for any row [11] at
codes [2-5].
12. Januvia (sitagliptin) Autocode if, for any row [12] at
codes [2-5].
13. Jentadueto (linagliptin + metformin) Autocode if, for any row [13] at
codes [2-5].
14. Kombiglyze XR (saxagliptin + metformin) Autocode if, for any row [14] at
codes [2-5].
15. Qtern (dapagliflozin + saxagliptin) Autocode if, for any row [15] at
codes [2-5].
16. Segluromet (ertugliflozin + metformin hydrochloride) Autocode if, for any row [16] at
codes [2-5].
17. Synjardy (empagliflozin + metformin) Autocode if, for any row [17] at
codes [2-5].
18. Xigduo (dapagliflozin+ metformin) Autocode if, for any row [18] at
codes [2-5].
19. Tradjenta (linagliptin) Autocode if, for any row [19] at
codes [2-5].
20. Toujeo (insulin glargine) Autocode if, for any row [20] at
any codes [2-5].
21. Tresiba (insulin degludec) Autocode if, for any row [21] at
any codes [2-5].
22. Trulicity (dulaglutide) Autocode if, for any row [22] at
any codes [2-5].
23. Victoza (liraglutide) Autocode if, for any row [23] at
any codes [2-5].
24. Trijardy XR (empagliflozin + linagliptin + metformin Autocode if, for any row [24] at
hydrochloride) S10_OralMed_Usage, the respondent selected any
codes [2-5].

[DV_BrandsFamiliar]
- Hidden Question. Applies to all. Autocode row stubs selected at any of these column(s) [3-5] at S11_Injections_Usage OR
selected at any of these column(s) [3-5] at S10_OralMed_Usage.
[IKnowA, HaveUsedIt, ICurrentlyUse]
DV_BrandsFamiliar. AIDED BRAND FAMILIARITY. Capture all brands familiar with from S10 & S11
DEFAULT ORDER.
1. Steglujan (ertugliflozin + sitagliptin)
2. Steglatro (ertugliflozin)
3. Rybelsus (semaglutide)
4. Jardiance (empagliflozin)
5. Farxiga (dapagliflozin)
6. Ozempic (semaglutide)
7. Glyxambi (empagliflozin + linagliptin)
8. Invokamet (canagliflozin + metformin)
9. Invokana (canagliflozin)
10. Janumet (sitagliptin + metformin)
11. Janumet XR (sitagliptin + metformin)
12. Januvia (sitagliptin)
13. Jentadueto (linagliptin + metformin)
14. Kombiglyze XR (saxagliptin + metformin)
15. Qtern (dapagliflozin + saxagliptin)
16. Segluromet (ertugliflozin + metformin hydrochloride)
17. Synjardy (empagliflozin + metformin)
18. Xigduo (dapagliflozin+ metformin)
19. Tradjenta (linagliptin)
20. Toujeo (insulin glargine)
21. Tresiba (insulin degludec)
22. Trulicity (dulaglutide)
23. Victoza (liraglutide)
24. Trijardy XR (empagliflozin + linagliptin + metformin
hydrochloride)

[DV_CurrentMedUsage]
- Hidden Question. Applies to all. Autocode row stubs selected at any of these column(s) [5] at S10_OralMed_Usage OR selected at
any of these column(s) [5] at S11_Injections_Usage.
[ICurrentlyUse]
TERM IMMEDIATELY IF 7 OR MORE STUBS ARE AUTOCODED HERE
DV_CurrentMedUsage. CURRENT MEDICATION USAGE. Hidden variable to capture current type 2 diabetes medication from S10 & S11
DEFAULT ORDER.
1. Steglujan (ertugliflozin + sitagliptin) Autocode if, for any row [1] at
S10_OralMed_Usage, the respondent selected
code [5].
2. Steglatro (ertugliflozin) Autocode if, for any row [2] at
code [5].
3. Rybelsus (semaglutide) Autocode if, for any row [3] at
code [5].
4. Jardiance (empagliflozin) Autocode if, for any row [4] at
code [5].
5. Farxiga (dapagliflozin) Autocode if, for any row [5] at
code [5].
6. Ozempic (semaglutide) Autocode if, for any row [6] at
code [5].
7. Glyxambi (empagliflozin + linagliptin) Autocode if, for any row [7] at
code [5].
8. Invokamet (canagliflozin + metformin) Autocode if, for any row [8] at
code [5].
9. Invokana (canagliflozin) Autocode if, for any row [9] at
code [5].
10. Janumet (sitagliptin + metformin) Autocode if, for any row [10] at
code [5].
11. Janumet XR (sitagliptin + metformin) Autocode if, for any row [11] at
code [5].
12. Januvia (sitagliptin) Autocode if, for any row [12] at
code [5].
13. Jentadueto (linagliptin + metformin) Autocode if, for any row [13] at
code [5].
14. Kombiglyze XR (saxagliptin + metformin) Autocode if, for any row [14] at
code [5].
15. Qtern (dapagliflozin + saxagliptin) Autocode if, for any row [15] at
code [5].
16. Segluromet (ertugliflozin + metformin hydrochloride) Autocode if, for any row [16] at
code [5].
17. Synjardy (empagliflozin + metformin) Autocode if, for any row [17] at
code [5].
18. Xigduo (dapagliflozin+ metformin) Autocode if, for any row [18] at
code [5].
19. Tradjenta (linagliptin) Autocode if, for any row [19] at
code [5].
20. Toujeo (insulin glargine) Autocode if, for any row [20] at
code [5].
21. Tresiba (insulin degludec) Autocode if, for any row [21] at
code [5].
22. Trulicity (dulaglutide) Autocode if, for any row [22] at
code [5].
23. Victoza (liraglutide) Autocode if, for any row [23] at
code [5].

24. Trijardy XR (empagliflozin + linagliptin + metformin Autocode if, for any row [24] at
hydrochloride) S10_OralMed_Usage, the respondent selected
code [5].
[DV_MedClass_Usage]
DV_MedClass_Usage. Capture med classes of all current prescriptions from S10 and S11.
DEFAULT ORDER.
1. DPP-4 Autocode if respondent selected any codes [12,
19] at DV_CurrentMedUsage.
2. SGLT-2 Autocode if respondent selected any codes [2, 4-5,
3. GLP1 Autocode if respondent selected any codes [3, 6,
22-23] at DV_CurrentMedUsage.
4. Insulin Autocode if respondent selected any codes [20-
5. SGLT2+DPP4 Autocode if respondent selected any codes [1, 7,
6. SGLT2+Metformin Autocode if respondent selected any codes [8, 16-
7. DPP4+Metformin Autocode if respondent selected any codes [10-11,
13-14] at DV_CurrentMedUsage.
8. SGLT2+DPP4+Metformin Autocode if respondent selected code [24] at
DV_CurrentMedUsage.
[DV_SteglujanFranUser]
DV_SteglujanFranUser. Capture Users of Steglujan Franchise.
DEFAULT ORDER.
1. Steglujan Franchise User Autocode if respondent selected any codes [1-2,
2. Non-Steglujan Franchise User Autocode if respondent did NOT select codes [1-2,
[DV_PastUsage]
- Hidden Question. Applies to all. Autocode row stubs selected at any of these column(s) [4] at S10_OralMed_Usage OR selected at
any of these column(s) [4] at S11_Injections_Usage.
[HaveUsedIt]
DV_PastUsage. PAST MEDICATION USAGE. Hidden variable to capture past type 2 diabetes medication from S10 & S11
DEFAULT ORDER.
7. Glyxambi (empagliflozin + linagliptin)
8. Invokamet (canagliflozin + metformin)
10. Janumet (sitagliptin + metformin)
11. Janumet XR (sitagliptin + metformin)
13. Jentadueto (linagliptin + metformin)
14. Kombiglyze XR (saxagliptin + metformin)
15. Qtern (dapagliflozin + saxagliptin)
17. Synjardy (empagliflozin + metformin)
18. Xigduo (dapagliflozin+ metformin)
21. Tresiba (insulin degludec)
24. Trijardy XR (empagliflozin + linagliptin + metformin
hydrochloride)

[DV_Total_FamCount]
- Programmer Comment: [PROJECT: This will help determine if we need to adjust the assignment scheme.]
DV_Total_FamCount. Capture sum of all meds & main brands aware and familiar with.
Enter numeric responses.

ROWS: DEFAULT ORDER. Num
1. AWARE - All Type 2
[1] PC: Sum of meds punched at DV_BrandsAware
Diabetes Meds
2. AWARE - Main Type 2 PC: Sum of main meds punched at DV_BrandsAware [Steglujan, Steglatro, Rybelsus, Jardiance, Farxiga,
[1]
Diabetes Meds Ozempic, Invokana, Trulicity]
3. FAMILIAR - All Type 2
[1] PC: Sum of meds punched at DV_BrandsFamiliar
Diabetes Meds
4. FAMILIAR - Main Type PC: Sum of main meds punched at DV_BrandsFamiliar [Steglujan, Steglatro, Rybelsus, Jardiance,
[1]
2 Diabetes Meds Farxiga, Ozempic, Invokana, Trulicity]
MIN: 0. MAX:
50. INTEGER
NUMERIC
RESPONSE
S.
Subsection Start - Segmentation Measures
[Steg_Segmentation]
- Show to all.
DT_Steg_Segmentation. On the following screens you will see a few questions that may reflect how you think about your health and
lifestyle.
[SegmentQ1]
- Show to all.
S12_SegmentQ1. Please review each pair of statements below, and choose the one that best describes you.
You may identify with both statements, but please choose the one that is the closest match.
RANDOMIZE LIST.
Describes Describes
Describes me better me better me better Describes me better
I don’t spend much time
1. I constantly worry about
worrying about developing
developing complications 1 2
complications with my
with my diabetes
diabetes
I don’t feel like others
2. I feel like others judge
1 2 judge me for having
me for having diabetes
diabetes
3. Life gets in the way of I don’t let life get in the way
1 2
managing my diabetes of managing my diabetes
4. I find it hard to get
I am highly motivated to
motivated to treat my 1 2
treat my diabetes
diabetes
[SegmentQ2]
- Show to all.
S13_SegmentQ2. Please indicate how much you agree with the following statement:
“I am constantly looking for new information to help improve my control over diabetes.”
DEFAULT ORDER.
1. 1 – Completely disagree
2. 2
3. 3
4. 4 - Neither agree nor disagree
5. 5
6. 6
7. 7 – Completely agree

[SegmentQ3]
- Show to all.
S14_SegmentQ3. Which of the following devices have you used for online/digital activity in the last month?
RANDOMIZE LIST.
1. Desktop computer
2. Laptop computer
3. Smartphone
4. Tablet (iPad, Kindle Fire, Surface, Galaxy Tab, etc.)
6. Smart home device (Amazon Echo (Alexa), Google
Home, etc.)
8. Wearable technology (Apple Watch, Samsung Gear,
Fitbit, Garmin, etc.)
[SegmentQ4]
- Show if respondent selected code [3] at S14_SegmentQ3.
S15_SegmentQ4. How would you rate your skill level using your smartphone compared to others who are about the same age as you?
DEFAULT ORDER.
1. Much worse – 1
2. 2
3. 3
4. About the same - 4
5. 5
6. 6
7. Much better- 7
[DV_Steg_Segment]
- Programmer Comment: See files in this folder for segmentation implementation: P:\202_Tischler\202-191284 Merck Steglujan 2020
Consumer Tracking\2_Project Design\Questionnaire\Exhibits & Stimuli\Segmentation Materials
DV_Steg_Segment. Captures Steglujan segmentation output
DEFAULT ORDER.
1. Aspiring Achievers
2. Managers
3. Disengaged

[AttentiveBipolar]
- Show to all.
- Programmer Comment: Please do not include question in segmentation algorithm.
S16_AttentiveBipolar. And just like before, please review each pair of statements below, and choose the one that you agree with the
most.
While you may agree with both statements, please choose the one that fits you best.
RANDOMIZE LIST.
Agree Agree
Agree More More More Agree More
1. I proactively talk to my
I let my doctor do most of
doctor about what I have
1 2 the talking when it comes
learned about diabetes
to diabetes medication(s)
medication(s)
2. I actively seek out I don't do much research
information on the internet on the internet about
1 2
about different prescription prescription diabetes
diabetes medications medications
3. I maintain a healthy diet 1 2 I eat whatever I want
4. I pay attention to I don't pay attention to
advertisements about advertisements about
1 2
prescription medications prescription medications
that are relevant to me that are relevant to me
5. I would like to find new
I am not interested in using
ways to use technology,
1 2 technology to manage my
like smartphones, to help
diabetes
me manage my diabetes
6. I have asked about a I have never asked my
prescription medication by 1 2 doctor about a prescription
brand name medication by brand name
7. I avoid taking new
I have no problem taking
prescription diabetes
1 2 new prescription diabetes
medications until they have
medications
been used for a long time
Subsection End - Segmentation Measures

TREATMENT BRAND FUNNEL
[DV_Brands_Eligible]
DV_Brands_Eligible. DV to capture the brands a respondent is eligible to be assigned at DV_Brands_Assigned
RANDOMIZE LIST.
1. Steglujan (ertugliflozin + sitagliptin) Autocode if respondent selected code [1] at
DV_BrandsAware.
2. Steglatro (ertugliflozin) Autocode if respondent selected code [2] at
DV_BrandsAware.
3. Rybelsus (semaglutide) Autocode if respondent selected code [3] at
DV_BrandsAware.
4. Jardiance (empagliflozin) Autocode if respondent selected code [4] at
DV_BrandsAware.
5. Farxiga (dapagliflozin) Autocode if respondent selected code [5] at
DV_BrandsAware.
6. Ozempic (semaglutide) Autocode if respondent selected code [6] at
DV_BrandsAware.
9. Invokana (canagliflozin) Autocode if respondent selected code [9] at
DV_BrandsAware.
22. Trulicity (dulaglutide) Autocode if respondent selected code [22] at
DV_BrandsAware.
[DV_Brands_Assigned]
DV_Brands_Assigned. Assigner
Eligibility variable: DV_Brands_Eligible

Maximum number of categories to assign: 4
If less than 1 category is assigned: Continue, but skip questions with logic referencing DV_Brands_Assigned
Step 1:
Assignment type: Most Needed
Maximum number of categories that can be assigned to this step: 2
Only assign specific categories?: Yes, one or more stubs from the eligibility variable
Steglujan (ertugliflozin + sitagliptin)

Steglatro (ertugliflozin)
Programmer Comment: Please assign Steglujan (if eligible/punched at DV_BrandsAware) and Steglatro (if eligible/punched at
DV_BrandsAware)
Step 2:
Only assign specific categories?: No, anything eligible can be assigned
Programmer Comment: Please assign 3-4 brands from the MedBrands_MainBrands list that were punched at DV_BrandsAware. Please
exclude Steglujan and Steglatro since they were already assigned in Step 1 if eligible.Each respondent should be assigned a maximum of 4
brands total in steps 1 and 2 combined.
[A_Intro]
- Show to all.
DT_A_Intro. Thank you for your interest in our survey! We appreciate your time and effort. Your input is very important to us.
In the questions that follow, we would like to better understand your experience with treating your Type 2 Diabetes.

[BrandAwareSource]
- Show if respondent selected any codes [1-6, 9, 22] at DV_Brands_Assigned.
- Repeat column headers after every 5 rows
- Answer by column.
A1_BrandAwareSource. Earlier you mentioned that you are aware of the Type 2 Diabetes medications below. How did you become
aware of each of these brands?
Please select all that apply for the brand(s) you are aware of.
Columns
RANDOMIZE LIST.
1. Steglujan (ertugliflozin + sitagliptin) Show if respondent selected code [1] at
DV_Brands_Assigned.
2. Steglatro (ertugliflozin) Show if respondent selected code [2] at
DV_Brands_Assigned.
3. Rybelsus (semaglutide) Show if respondent selected code [3] at
DV_Brands_Assigned.
4. Jardiance (empagliflozin) Show if respondent selected code [4] at
DV_Brands_Assigned.
5. Farxiga (dapagliflozin) Show if respondent selected code [5] at
DV_Brands_Assigned.
6. Ozempic (semaglutide) Show if respondent selected code [6] at
DV_Brands_Assigned.
9. Invokana (canagliflozin) Show if respondent selected code [9] at
DV_Brands_Assigned.
22. Trulicity (dulaglutide) Show if respondent selected code [22] at
DV_Brands_Assigned.
COLS: RANDOMIZE LIST. [COLUMN

ROWS: RANDOMIZE LIST. LABEL]
1. Television ad [#]
2. Magazine ad [#]
3. Internet banner ad [#]
4. Online video ad [#]
5. Radio ad [#]
6. Direct mail [#]
7. Mobile app [#]
8. Signage/billboard [#]
9. From a doctor [#]
10. Newspaper ad [#]
11. In an email [#]
12. On social media (e.g.
[#]
Twitter, Facebook, etc.)
13. In search engine
results (e.g. Google, [#]
Yahoo, etc.)
14. From a friend or family
[#]
member
15. An online community
or message board not on a [#]
social media site
97. Somewhere else [#] ANCHOR.
99. Not sure [#] ANCHOR. EXCLUSIVE.

[FirstBrandAware]
- Show if, for any column [1-2] at A1_BrandAwareSource, the respondent selected any codes [1-15, 97].
- Answer by column.
A12_FirstBrandAware. How did you first become aware of each of these brands?
Steglujan
(ertugliflozi Steglatro
COLS: RANDOMIZE LIST. n+ (ertugliflozi
ROWS: RANDOMIZE LIST. sitagliptin) n)
Show if, for any column [1-2] at A1_BrandAwareSource, the respondent selected code
1. Television ad 1 2
[1].
2. Magazine ad 1 2
[2].
3. Internet banner ad 1 2
[3].
4. Online video ad 1 2
[4].
5. Radio ad 1 2
[5].
6. Direct mail 1 2
[6].
7. Mobile app 1 2
[7].
8. Signage/billboard 1 2
[8].
9. From a doctor 1 2
[9].
10. Newspaper ad 1 2
[10].
11. In an email 1 2
[11].
12. On social media (e.g. Show if, for any column [1-2] at A1_BrandAwareSource, the respondent selected code
1 2
Twitter, Facebook, etc.) [12].
13. In search engine
results (e.g. Google, 1 2
[13].
Yahoo, etc.)
14. From a friend or family Show if, for any column [1-2] at A1_BrandAwareSource, the respondent selected code
1 2
member [14].
15. An online community
or message board not on a 1 2
[15].
social media site
ANCHOR. Show if, for any column [1-2] at A1_BrandAwareSource, the respondent
97. Somewhere else 1 2
selected code [97].

Show if, for Show if, for
any column any column
[1] at [2] at
A1_BrandA A1_BrandA
wareSource, wareSource,
the the
respondent respondent
did NOT did NOT
select code select code
[99]. PC: [99]. PC:
Show if Show if
more than more than
one stub one stub
was selected was
under selected
Steglujan [1] under
at Steglatro [2]
A1_BrandA at
wareSource. A1_BrandA
If only one wareSource.
stub If only one
selected that stub
is not "Not selected that
Sure" [99], is not "Not
autocode as Sure" [99],
first source autocode as
of first source
awareness of
and hide awareness
column. and hide
Only show column.
stubs Only show
selected for stubs
this column selected for
in this column
A1_BrandA in
wareSource A1_BrandA
wareSource
Loop Start - BrandRatings
[BrandRatings]
BrandRatings. BrandRatings
Iterations:
RANDOMIZE LIST.
DV_Brands_Assigned.
DV_Brands_Assigned.
DV_Brands_Assigned.
DV_Brands_Assigned.
DV_Brands_Assigned.
DV_Brands_Assigned.
DV_Brands_Assigned.
DV_Brands_Assigned.
Questions:

[TreatmentPerformance]
- Programmer Comment: For data from Wave1January - Wave6June, please re-code columns [2,3,4] as code [2 - Somewhat
describes] and re-code column [5] as code [3 - Describes very well] for RFS data and tabs.
A2_TreatmentPerformance. In your opinion, how well does each attribute below describe [Insert current iteration]?
Does not
COLS: DEFAULT ORDER. describe at Somewhat Describes
ROWS: RANDOMIZE LIST. all describes very well
1. Effectively does 3
things - enhances my
body’s ability to make less 1 2 3
sugar, make more insulin,
and remove sugar
2. Is a medication that
would work as hard as I do 1 2 3
to manage my diabetes
3. Is a powerful
1 2 3
medication
4. Is a combination of two
1 2 3
types of medications
5. Is a medication I can
1 2 3
trust
6. Would significantly
1 2 3
lower my A1C
7. May help me lose some
1 2 3
weight
8. Works differently than
other Type 2 Diabetes 1 2 3
medications
9. May help lower blood
1 2 3
pressure
10. Helps reduce my risk
1 2 3
of dying from heart disease
11. Helps rid my body of
excess sugar through 1 2 3
urination
12. Is a once daily pill 1 2 3
13. Is the medication
brand that understands my
1 2 3 PC: Suppress for July'20 onward
experience with Type 2
Diabetes
Loop End - BrandRatings

[Usage_Duration]
- Show to all. Only show row stubs selected at DV_CurrentMedUsage.
- Programmer Comment: Show all brands punched at DV_CurrentMedUsage
For data from old 5-pt scale, please re-code "0-3 months" and "4-6 months" as code [1 - Less than 6 months], and re-code "7-12
months" as code [2 - 6 months to a year], and re-code "1-2 years" and "More than 2 years" as code [4 - More than a year] for RFS
data and tabs.
A3_Usage_Duration. You mentioned currently taking the following medication(s). For how long have you been taking each of them?

ROWS: ALPHABETICAL Less than 6 months More than
ORDER. 6 months to a year a year
1 2 4
sitagliptin)
2. Steglatro (ertugliflozin) 1 2 4
3. Rybelsus (semaglutide) 1 2 4
4. Jardiance
1 2 4
(empagliflozin)
5. Farxiga (dapagliflozin) 1 2 4
6. Ozempic (semaglutide) 1 2 4
1 2 4
+ linagliptin)
1 2 4
+ metformin)
9. Invokana (canagliflozin) 1 2 4
1 2 4
metformin)
11. Janumet XR
1 2 4
12. Januvia (sitagliptin) 1 2 4
1 2 4
+ metformin)
14. Kombiglyze XR
1 2 4
1 2 4
saxagliptin)
16. Segluromet
(ertugliflozin + metformin 1 2 4
hydrochloride)
17. Synjardy
1 2 4
(empagliflozin + metformin)
18. Xigduo (dapagliflozin+
1 2 4
metformin)
19. Tradjenta (linagliptin) 1 2 4
20. Toujeo (insulin
1 2 4
glargine)
1 2 4
degludec)
22. Trulicity (dulaglutide) 1 2 4
23. Victoza (liraglutide) 1 2 4
24. Trijardy XR
(empagliflozin + linagliptin 1 2 4

[DV_MedClass_Duration]
DV_MedClass_Duration. Captures whether recent or long-term user of med-class
DEFAULT ORDER.
DEFAULT ORDER. Header: Oral prescriptions.
1. Recent DPP-4 Autocode if, for any row [12, 19] at
A3_Usage_Duration, the respondent selected any
codes [1-2].
2. Recent SGLT-2 Autocode if, for any row [2, 4-5, 9] at
codes [1-2].
8. Long-Term DPP-4 Autocode if, for any row [12, 19] at
A3_Usage_Duration, the respondent selected
code [4].
9. Long-Term SGLT-2 Autocode if, for any row [2, 4-5, 9] at
code [4].
DEFAULT ORDER. Header: Insulin/Injectible.
3. Recent GLP1 Autocode if, for any row [3, 6, 22-23] at
codes [1-2].
4. Recent Insulin Autocode if, for any row [20-21] at
codes [1-2].
10. Long-Term GLP1 Autocode if, for any row [3, 6, 22-23] at
code [4].
11. Long-Term Insulin Autocode if, for any row [20-21] at
code [4].
DEFAULT ORDER. Header: Combo Treatments.
5. Recent SGLT2+DPP4 Autocode if, for any row [1, 7, 15] at
codes [1-2].
6. Recent SGLT2+Metformin Autocode if, for any row [8, 16-18] at
codes [1-2].
7. Recent DPP4+Metformin Autocode if, for any row [10-11, 13-14] at
codes [1-2].
15. Recent SGLT2+DPP4+Metformin Autocode if, for any row [24] at
codes [1-2].
12. Long-term SGLT2+DPP4 Autocode if, for any row [1, 7, 15] at
code [4].
13. Long-term SGLT2+Metformin Autocode if, for any row [8, 16-18] at
code [4].
14. Long-term DPP4+Metformin Autocode if, for any row [10-11, 13-14] at
code [4].
16. Long-term SGLT2+DPP4+Metformin Autocode if, for any row [24] at
code [4].
[DV_Steglujan_Duration]
DV_Steglujan_Duration. Captures duration of use for Steglujan
DEFAULT ORDER.
1. Recent Steglujan User Autocode if, for any row [1] at
codes [1-2].
2. Long-term Steglujan User Autocode if, for any row [1] at
code [4].
3. Steglujan Non-User Autocode if respondent did NOT select codes [1-2]
at DV_Steglujan_Duration.

[UseSamples]
- Show if respondent selected any codes [1-6, 9, 22] at DV_CurrentMedUsage. Only show row stubs selected at
DV_CurrentMedUsage.
- Programmer Comment: Show all brands punched at DV_MedCurrentUsage
A4_UseSamples. For which of the medication(s) you are currently taking has your doctor given you samples, if any?
ALPHABETICAL ORDER.
7. Glyxambi (empagliflozin + linagliptin) PC: Suppress July'20 onward
8. Invokamet (canagliflozin + metformin) PC: Suppress July'20 onward
10. Janumet (sitagliptin + metformin) PC: Suppress July'20 onward
11. Janumet XR (sitagliptin + metformin) PC: Suppress July'20 onward
12. Januvia (sitagliptin) PC: Suppress July'20 onward
13. Jentadueto (linagliptin + metformin) PC: Suppress July'20 onward
14. Kombiglyze XR (saxagliptin + metformin) PC: Suppress July'20 onward
15. Qtern (dapagliflozin + saxagliptin) PC: Suppress July'20 onward
17. Synjardy (empagliflozin + metformin) PC: Suppress July'20 onward
18. Xigduo (dapagliflozin+ metformin) PC: Suppress July'20 onward
19. Tradjenta (linagliptin) PC: Suppress July'20 onward
20. Toujeo (insulin glargine) PC: Suppress July'20 onward
21. Tresiba (insulin degludec) PC: Suppress July'20 onward
23. Victoza (liraglutide) PC: Suppress July'20 onward
24. Trijardy XR (empagliflozin + linagliptin + metformin PC: Suppress July'20 onward
hydrochloride)
[MedSatisfaction]
- Show if respondent selected any codes [1-6, 9, 22] at DV_CurrentMedUsage. Only show row stubs selected at
DV_CurrentMedUsage.
- Programmer Comment:
A5_MedSatisfaction. How satisfied are you with your current medication(s) for the treatment of your Type 2 Diabetes?

ROWS: ALPHABETICAL Dissatisfie Somewhat Very
ORDER. d satisfied satisfied
1 2 3
sitagliptin)
4. Jardiance
1 2 3
(empagliflozin)
Loop Start - ReasonsSwitch

[ReasonsSwitch]
- Show if respondent selected any codes [1-6, 9, 22] at DV_PastUsage.
ReasonsSwitch. ReasonsSwitch
Iterations:
RANDOMIZE LIST.
DV_PastUsage.
DV_PastUsage.
DV_PastUsage.
DV_PastUsage.
DV_PastUsage.
DV_PastUsage.
DV_PastUsage.
DV_PastUsage.
Questions:
[ReasonSwitchOffSteg]
- Show if respondent selected any codes [1-6, 9, 22] at DV_PastUsage.
- Programmer Comment: Suppress 2021 onward
A6_ReasonSwitchOffSteg. You mentioned you used to be on [Insert current iteration], but are now on a different type 2 diabetes
medication. Why did your doctor switch you off of [Insert current iteration]?
RANDOMIZE LIST.
1. It wasn’t easy to refill my prescription
2. My insurance coverage changed
3. I do not believe it is an effective treatment for Type 2
Diabetes
4. I prefer to get a generic medication
5. I prefer injectable medication to an oral
6. My doctor believed a different drug would work better for
my Type 2 Diabetes
97. Other ANCHOR.
Loop End - ReasonsSwitch

[ConsiderAskingDr]
- Show if Respondent is assigned the medication [DV_BrandsAssigned] but is NOT currently using it [DV_CurrentMeds]..
- Programmer Comment: For data from Wave1January - Wave6June, please re-code columns [1, 2] as code [1 - Not very likely], re-
code column [3] as code [2 - Somewhat likely], and re-code columns [4,5] as [3 - Very likely] for RFS data and tabs.
A7_ConsiderAskingDr. Thinking about the next time you talk to your doctor to discuss your Type 2 Diabetes, how likely are you to ask
your doctor about their opinions of the medication(s) below in terms of whether it would be right for you?
COLS: DEFAULT ORDER. Not very Somewhat

ROWS: RANDOMIZE LIST. likely likely Very likely
1. Steglujan (ertugliflozin + Show if (respondent selected code [1] at DV_Brands_Assigned AND
1 2 3
sitagliptin) respondent did NOT select code [1] at DV_CurrentMedUsage).
Show if (respondent selected code [2] at DV_Brands_Assigned AND
respondent did NOT select code [2] at DV_CurrentMedUsage).
4. Jardiance Show if (respondent selected code [4] at DV_Brands_Assigned AND
1 2 3
(empagliflozin) respondent did NOT select code [4] at DV_CurrentMedUsage).
Loop Start - BrandConsiderations
[BrandConsiderations]
BrandConsiderations BrandConsiderations
.
Iterations:
RANDOMIZE LIST.
1. Steglujan (ertugliflozin + sitagliptin) Show if (respondent selected code [1] at
DV_Brands_Assigned AND respondent did NOT
select code [1] at DV_CurrentMedUsage).
2. Steglatro (ertugliflozin) Show if (respondent selected code [2] at
3. Rybelsus (semaglutide) Show if (respondent selected code [3] at
4. Jardiance (empagliflozin) Show if (respondent selected code [4] at
5. Farxiga (dapagliflozin) Show if (respondent selected code [5] at
6. Ozempic (semaglutide) Show if (respondent selected code [6] at
9. Invokana (canagliflozin) Show if (respondent selected code [9] at
22. Trulicity (dulaglutide) Show if (respondent selected code [22] at
Questions:

[ReasonsToConsider]
- Show if, for any row [1-6, 9, 22] at A7_ConsiderAskingDr, the respondent selected code [3]. Only show row stubs selected at any
of these column(s) [3] at A7_ConsiderAskingDr.
A8_ReasonsToConsider. What are the reasons you might be very likely to ask your doctor whether [Insert current iteration] would be
right for you?
RANDOMIZE LIST.
1. My doctor previously shared medication information about PC: Suppress July'20 onward
[Insert current iteration] with me
2. [Insert current iteration] seems to have few side effects
3. I’m dissatisfied with my current medication(s)
4. [Insert current iteration] seems different from other Type 2
Diabetes medications
5. I saw an ad for [Insert current iteration]
6. I relate to [Insert current iteration] advertising
7. I think I have enough information to feel comfortable
considering [Insert current iteration]
8. I want more information about [Insert current iteration]
9. I think [Insert current iteration] really understands me and
my diabetes
10. I have a friend or relative on the medication and it's PC: Suppress July'20 onward
working for them
11. I think it might be more effective than my current
medication(s)
12. I think medications that are a combination of two different Show if respondent is in any of these iterations
types of medications are more effective [1].
13. It would be more convenient to take [Insert current
iteration] than other medications
97. Some other reason ANCHOR.
[ReasonsNotConsider]
- Show if, for any row [1-6, 9, 22] at A7_ConsiderAskingDr, the respondent selected any codes [1-2]. Only show row stubs selected
at any of these column(s) [1-2] at A7_ConsiderAskingDr.
A9_ReasonsNotConsider. What are the reasons you might not be very likely to ask your doctor whether [Insert current iteration] would
be right for you?
RANDOMIZE LIST.
1. I don’t have enough information about [Insert current
iteration]
2. I typically wait for my doctor to share medication
information with me
3. [Insert current iteration] seems like it has too many side
effects
4. I’m satisfied with my current medications(s)
5. There is nothing different about [Insert current iteration]
that motivates me to ask my doctor about it
6. I don’t want to start taking a new medication
7. I’m focusing on making lifestyle changes to manage my
diabetes (e.g. losing weight, changing diet, etc.)
8. I don’t relate to [Insert current iteration] advertising
9. I prefer to get a generic medication
10. I think {@) is less effective than my current medications
11. I don’t think combination medications work well Show if respondent is in any of these iterations
[1].
97. Some other reason ANCHOR.
Loop End - BrandConsiderations

[ConsiderSwitching]
- Show if respondent selected any codes [1-6, 9-12, 22] at DV_CurrentMedUsage. Only show row stubs selected at
DV_CurrentMedUsage.
- Programmer Comment:
A10_ConsiderSwitching. How likely are you to switch off each of your medication(s) below if you found out about another option, or a
doctor recommended switching medications?
COLS: DEFAULT ORDER. Not very Somewhat

ROWS: ALPHABETICAL likely to likely to Very likely
ORDER. switch switch to switch
1 2 3
sitagliptin)
4. Jardiance
1 2 3
(empagliflozin)
1 2 3
metformin)
11. Janumet XR
1 2 3
12. Januvia (sitagliptin) 1 2 3
[OpenToAddingMed]
- Show to all.
A11_OpenToAddingMed. If your doctor talked to you about adding an additional medication to your current treatment, how open would
you be to adding it?
DEFAULT ORDER.
1. Not at all open
2. Somewhat open
3. Very open

COMMUNICATIONS
[B_Intro]
- Show to all.
DT_B_Intro. In the next questions we would like to know more about what you may have heard or seen about different Type 2 Diabetes
medication(s).
[Ad_UnaidedAwareness]
- Show to all.
- Programmer Comment: Don't allow respondents to skip boxes.
Capture first mention as DV_TopOfMind_Ad.
Error message if respondent skips a box: Please make sure no boxes are skipped in your response(s).
Error Message if respondent types under 3 characters: Please check your response(s) and ensure they are fully spelled out.
Error message if respondent tries to skip question without filling out any boxes and not clicking opt-out box: Please select "I can't
think of any" if you cannot think of any medications.
if needed example function can be found here: \\cnc-fsh-106p.elrw.com\Projects2019\006_IPS\Questions - Code and

Templates\Custom Functions\FUNCTION_Text grid validation with opt out and correct order of boxes filled out.txt
B1_Ad_UnaidedAwareness. What prescription medications for Type 2 Diabetes have you heard or seen an advertisement for in the
past 3 months?
"Advertising" can refer to TV, online, social media, emails, newspapers, magazines, pharmacy inserts, ads at
a doctor's office, etc.
Enter your response(s) in the box(es). Please type in all medications for this condition that come to mind,
even if you've already mentioned it.

ROWS: DEFAULT ORDER.
1. 1 [] PC: Record as TOM
2. 2 []
3. 3 []
4. 4 []
5. 5 []
6. 6 []
7. 7 []
8. 8 []
99. I can't think of any [] PC: Opt out option
MIN: 3. MAX:
200.
[DV_TopOfMindAd]
DV_TopOfMindAd. Captures first mention from B1.
Enter your response in the box.
MIN: 3. MAX: 200.

[Ad_AidedAwareness]
- Show to all.
B2_Ad_AidedAwareness. Even though you may have mentioned some of these earlier, please indicate all of the Type 2 Diabetes
medications for which you have heard or seen an advertisement for in the past 3 months.
"Advertising" can refer to TV ads, online, social media, emails, newspapers, magazines, pharmacy inserts, ads
at a doctor's office, etc.
ALPHABETICAL ORDER.
DV_BrandsAware.
DV_BrandsAware.
DV_BrandsAware.
DV_BrandsAware.
DV_BrandsAware.
DV_BrandsAware.
DV_BrandsAware.
DV_BrandsAware.
[AdAwarenessSources]
- Show to all.
- Answer by column.
B3_AdAwarenessSources. You mentioned that you heard or saw advertising for the medication(s) below in the past 3 months. Where did
you see advertisements for each of these medication brands?
Please select all that apply for the brand(s) you have seen advertised.
Columns
DEFAULT ORDER.
B2_Ad_AidedAwareness.
COLS: DEFAULT ORDER. [COLUMN

1. Television [#]
2. Magazine [#]
3. Internet banner ad [#]
4. Online video ad [#]
5. Radio [#]
6. Direct mail [#]
7. Mobile app [#]
8. Signage/billboard [#]
9. In doctor’s office [#]
10. Newspaper [#]
11. In an email [#]
12. On social media (e.g.
[#]
Twitter, Facebook, etc.)
97. Somewhere else [#] ANCHOR.
98. Not sure [#] ANCHOR. EXCLUSIVE.

[SocialMediaAware]
- Show if, for any column at B3_AdAwarenessSources, the respondent selected code [12].
- Answer by column.
B4_SocialMediaAware. In which social media site(s) do you recall seeing advertising for the brand(s) below?
Please select all that apply for each brand.
Columns
DEFAULT ORDER.
1. Steglujan (ertugliflozin + sitagliptin) Show if, for any column [1] at
B3_AdAwarenessSources, the respondent
selected code [12].
2. Steglatro (ertugliflozin) Show if, for any column [2] at
selected code [12].
3. Rybelsus (semaglutide) Show if, for any column [3] at
selected code [12].
4. Jardiance (empagliflozin) Show if, for any column [4] at
selected code [12].
5. Farxiga (dapagliflozin) Show if, for any column [5] at
selected code [12].
6. Ozempic (semaglutide) Show if, for any column [6] at
selected code [12].
9. Invokana (canagliflozin) Show if, for any column [9] at
selected code [12].
22. Trulicity (dulaglutide) Show if, for any column [22] at
selected code [12].

1. Facebook [#]
2. Twitter [#]
3. Tumblr [#]
4. LinkedIn [#]
6. Instagram [#]
7. YouTube [#]
8. Pinterest [#]
9. Other [#] ANCHOR.
10. I don’t remember [#] ANCHOR. EXCLUSIVE.

[DocOfficeAdAware]
- Show if, for any column at B3_AdAwarenessSources, the respondent selected code [9].
- Answer by column.
B5_DocOfficeAdAware. Where in the doctor’s office do you recall seeing advertising for the brand(s) below?
Please select all that apply for each brand.
Columns
DEFAULT ORDER.
1. Steglujan (ertugliflozin + sitagliptin) Show if, for any column [1] at
selected code [9].
2. Steglatro (ertugliflozin) Show if, for any column [2] at
selected code [9].
3. Rybelsus (semaglutide) Show if, for any column [3] at
selected code [9].
4. Jardiance (empagliflozin) Show if, for any column [4] at
selected code [9].
5. Farxiga (dapagliflozin) Show if, for any column [5] at
selected code [9].
6. Ozempic (semaglutide) Show if, for any column [6] at
selected code [9].
9. Invokana (canagliflozin) Show if, for any column [9] at
selected code [9].
22. Trulicity (dulaglutide) Show if, for any column [22] at
selected code [9].

1. On a TV in the waiting
[#]
room or office
2. On a poster [#]
3. On a tablet/iPad when I
[#]
checked in
4. In a pamphlet/brochure
[#]
in the office
97. Other [#] ANCHOR.
98. I don’t remember [#] ANCHOR. EXCLUSIVE.
Loop Start - AdMessageRecall

[AdMessageRecall]
- Show if respondent selected any codes [1-6, 9, 22] at B2_Ad_AidedAwareness.
AdMessageRecall. AdMessageRecall
Iterations:
DEFAULT ORDER.
Questions:
[Ad_MessageRecall]
- Show if respondent selected any codes [1-6, 9, 22] at B2_Ad_AidedAwareness.
B6_Ad_MessageRecall. Thinking specifically about what you saw, heard or read about [Insert current iteration], which of these
messages, if any, were part of the ad?
RANDOMIZE LIST.
1. Works in 3 ways – makes more insulin, makes less sugar,
and removes some sugar
2. Is a combination of two types of medications in one
3. May help you lose some weight
4. Works differently from other medications
5. Lowers A1C
6. Lowers blood sugar
7. It’s a daily pill
8. Pay as little as $5
9. May help to lower blood pressure
10. $0 co-pay
11. Helps reduce my risk of dying from heart disease PC: Stubs 11 and 12 should not appear next to
each other after randomization
12. If I already have heart disease, it helps reduce my risk of
dying from it
13. Is a new way to help control your diabetes
14. Makes me think that I could better manage my diabetes PC: Suppress 2021
15. Is a powerful medication
16. Would work better than the current treatment I’m taking
17. Would help me get to my A1C goal quickly
18. Is only taken once a week
19. May reduce the risk of hospitalization due to heart failure
Loop End - AdMessageRecall
[Ad_Intro]
- Show to all.
DT_Ad_Intro. Now, we will show you a set of print, web, and TV advertisements. Please answer the questions keeping in mind only the
ad that is shown.
Please do not think of other advertisements for the same brand or similar advertisements for other brands that you may
have seen.

[DV_AdsEligibile]
- Programmer Comment: Question previously programmed - referencing the 181148 study:
https://apps.lrwonline.com/WebAuthor/#/questionnaire/5639/
DV_AdsEligibile. Captures all ads that respondent is eligible to see
DEFAULT ORDER.
1. Steglujan TV Ad People PC: Suppress starting in Q2 2021 onward
2. Steglujan Web Ad 2
3. Steglujan Web Ad 1 - Savings PC: Suppress starting in Q2 2021 onward
17. Steglujan Web Ad 3 - Fill In Question PC: Suppress starting in Q3 2021 onward
18. Steglujan Web Ad 4 - Neon Savings
4. Steglujan FB Ad 1 - Neon Savings PC: Suppress starting in Q2 2021 onward
5. Steglujan FB Ad 2 - Silhouette
6. Steglujan Print Ad PC: Suppress 2021
7. Steglatro Web Ad - Hands PC: Suppress starting in Q2 2021 onward
8. Steglatro Print Ad PC: Suppress 2021
9. Ozempic TV Ad
10. Ozempic Web Ad PC: Suppress 2021
11. Rybelsus TV Ad
12. Jardiance TV Ad
13. Jardiance Web Ad PC: Suppress 2021
14. Farxiga TV Ad
15. Trulicity TV Ad
16. Invokana Print Ad PC: Suppress 2021
[DV_AdsAssigned]
DV_AdsAssigned. Assigner
Eligibility variable: DV_AdsEligibile

If less than 1 category is assigned: Terminate
Step 1:
Steglujan Web Ad 2
Steglujan Web Ad 4 - Neon Savings
Steglujan FB Ad 2 - Silhouette
Programmer Comment: Assign 2 of the 3 eligible Steglujan ads (Steglujan Web Ad 2, Steglujan Web Ad 4, and Steglujan FB Ad 2) in this
step.Don't assign the same ad twice in this step. The anticipated monthly base size (total monthly base size is approx. n=100) for each of the 3
eligible Steglujan ads should be n=66 or 67
Step 2:
Ozempic TV Ad
Rybelsus TV Ad
Jardiance TV Ad
Farxiga TV Ad
Trulicity TV Ad
Programmer Comment: Assign from the eligible ads from the 5 remaining brands only (Jardiance, Ozempic Trulicity, Farxiga, Rybelsus).Each
remaining brand (Jardiance, Ozempic Trulicity, Farxiga, Rybelsus) should have a similar base size overall, across all of its ad types. NO
Steglujan Ads should be assigned at this step (cannot assign any Steglujan TV Ads, Steglujan Web Ads, or Steglujan FB Ads).Approx.
anticipated monthly base size (total monthly base size is approx. n=100) for each eligible ad at this step:Jardiance TV Ad n=20Ozempic TV Ad
n=20Trulicity TV Ad n=20Farxiga TV Ad n=20Rybelsus TV Ad n=20
Loop Start - AdRecall_Diagnostics

[AdRecall_Diagnostics]
- Programmer Comment: Ad Stimuli found here: P:\202_Tischler\202-201705 Merck Steglujan 2021 Consumer Tracking\2_Project
Design\Questionnaire\Exhibits & Stimuli\For Programming
AdRecall_Diagnostics. AdRecall_Diagnostics
Iterations:
RANDOMIZE LIST.
1. Steglujan TV Ad People Show if respondent selected code [1] at
DV_AdsAssigned.
2. Steglujan Web Ad 2 Show if respondent selected code [2] at
DV_AdsAssigned.
3. Steglujan Web Ad 1 - Savings Show if respondent selected code [3] at
DV_AdsAssigned.
17. Steglujan Web Ad 3 - Fill In Question Show if respondent selected code [17] at
DV_AdsAssigned.
18. Steglujan Web Ad 4 - Neon Savings Show if respondent selected code [18] at
DV_AdsAssigned.
4. Steglujan FB Ad 1 - Neon Savings Show if respondent selected code [4] at
DV_AdsAssigned.
5. Steglujan FB Ad 2 - Silhouette Show if respondent selected code [5] at
DV_AdsAssigned.
7. Steglatro Web Ad - Hands Show if respondent selected code [7] at
DV_AdsAssigned.
9. Ozempic TV Ad Show if respondent selected code [9] at
DV_AdsAssigned.
11. Rybelsus TV Ad Show if respondent selected code [11] at
DV_AdsAssigned.
12. Jardiance TV Ad Show if respondent selected code [12] at
DV_AdsAssigned.
14. Farxiga TV Ad Show if respondent selected code [14] at
DV_AdsAssigned.
15. Trulicity TV Ad Show if respondent selected code [15] at
DV_AdsAssigned.
Questions:
[P3M_AdAware]
- Show to all.
- Programmer Comment: SHOW AD IMAGE ABOVE QUESTION
Ad Stimuli found here: P:\202_Tischler\202-201705 Merck Steglujan 2021 Consumer Tracking\2_Project

B7_P3M_AdAware. Have you seen this specific advertisement in the past 3 months or so?
Please provide your answers thinking of only this specific advertisement for the medication shown.
DEFAULT ORDER.
1. Yes
2. No
98. Not sure

[AdFrequency]
- Show if respondent selected code [1] at B7_P3M_AdAware.

B8_AdFrequency. How many times do you think you’ve seen this ad in the past 3 months?
DEFAULT ORDER.
1. Only once or twice
2. A few times
3. Many times
[AdEmotion]
- Show if respondent is in any of these iterations [1-5, 7, 17-18].

B9_AdEmotion. Which of the emotions below best describes how you would feel about being on the medication in this ad?
If none of these emotions exactly describe how you feel, please choose the emotion that is the closest match.
RANDOMIZE LIST.
1. Excited
2. Inspired
3. Satisfied
4. Pleased
5. Secure
6. At ease
7. Nervous
8. Angry
9. Troubled
10. Unhappy
11. Bored
12. Down
[AdBrandAssociation]

B10_AdBrandAssociation. Do you know which Type 2 Diabetes medication this ad is for?
RANDOMIZE LIST.
97. Other ANCHOR.
98. I cannot recall which specific medication this ad is for ANCHOR. EXCLUSIVE.

[DV_AdBrand_ID]
- Hidden Question. Applies if respondent selected code [1] at B7_P3M_AdAware.
DV_AdBrand_ID. Capture if respondents identify the brand seen in the ad accurately in B10.
DEFAULT ORDER.
1. Correctly Identified PC: Autocode if respondent selected the correct
brand for the ad iteration they're in.
They're correct if:
-They selected Steglujan [1] at
B10_AdBrandAssociation, and they're in the
Steglujan TV Ad - People, Steglujan Web Ad 1 -
Savings, Steglujan Web Ad 2, Steglujan Web Ad 3
- Fill In Question, Steglujan Web Ad 4 - Neon
Savings, Steglujan FB Ad 1 - Neon Savings, or
Steglujan FB Ad 2 - Silhouette iterations.
-They selected Steglatro [2] at
Steglatro Web Ad iteration.
-They selected Ozempic [6] at
Ozempic TV Ad iteration
-They selected Rybelsus [3] at
Rybelsus TV Ad iteration.
-They selected Jardiance [4] at
Jardiance TV Ad iteration
-They selected Farxiga [5] at
Farxiga TV Ad iteration
-They selected Trulicity [22] at
Trulicity TV Ad iteration
2. Incorrectly Identified Autocode if respondent did NOT select code [1] at
DV_AdBrand_ID.
[DV_InsertBrandName]
DV_InsertBrandName. Capture names of brands of ads shown for inserts at B11-B16
DEFAULT ORDER.
1. Steglujan Autocode if respondent is in any of these
iterations [1-5, 17-18].
2. Steglatro Autocode if respondent is in any of these
iterations [7].
3. Rybelsus Autocode if respondent is in any of these
iterations [11].
4. Jardiance Autocode if respondent is in any of these
iterations [12].
5. Ozempic Autocode if respondent is in any of these
iterations [9].
7. Farxiga Autocode if respondent is in any of these
iterations [14].
8. Trulicity Autocode if respondent is in any of these
iterations [15].

[AdEvaluation]
- Programmer Comment: SHOW AD ABOVE QUESTION

B11_AdEvaluation. You may have already mentioned it, but this ad is for [Insert response from DV_InsertBrandName].
Thinking about the [Insert response from DV_InsertBrandName] ad above, please indicate whether you agree or
disagree with the following statements using the scale below.
COLS: DEFAULT ORDER. Somewhat Strongly

ROWS: RANDOMIZE LIST. Disagree agree agree
1. It tells me something
1 2 3
new
2. It tells me something
1 2 3
important
3. The points in the ad are
1 2 3
believable
4. It makes me want to
learn more about the 1 2 3
medication
5. It is confusing 1 2 3
6. It makes me think this
medication is better than
1 2 3
other medications for Type
2 diabetes
7. It makes me want to tell
1 2 3 PC: Suppress 2021
others about the ad
8. It gets what I'm going
through with my Type 2 1 2 3
diabetes
9. Makes me feel that
{#DV_InsertBrandName}
1 2 3
would build on my efforts
to manage my diabetes
10. Makes me feel good
about 1 2 3
11. Makes me think
is different from other type 1 2 3
2 diabetes prescription
medication brands
12. Inspires me to live a
1 2 3 PC: Suppress 2021
healthier lifestyle

[ActionTakenBranded]
- Programmer Comment: SHOW AD ABOVE QUESTION

B12_ActionTakenBranded. In the past 3 months or so, which of the following actions have you taken as a result of seeing the [Insert
response from DV_InsertBrandName] ad above?
RANDOMIZE LIST.
1. Spoke to my doctor about the medication
2. Spoke to a nurse, a pharmacist, or another healthcare
provider about the medication
3. Asked for a prescription for the medication
4. Asked friends, family, or co-workers if they have heard of
the medication
5. Talked to people in my religious organization or
community group about the medication
6. Called the toll-free number shown on the ad
7. Went to the website shown on the ad
8. Searched the medication on the Internet
9. Used social media to learn what others are saying about
the medication
10. Looked for the medication elsewhere ANCHOR. PC: Suppress July'20 onward
99. Did not take any action ANCHOR. EXCLUSIVE.
[MethodHCPSpoke]
- Show if respondent selected any codes [1-2] at B12_ActionTakenBranded.
B20_MethodHCPSpoke. How did you speak with a healthcare professional about the medication?
RANDOMIZE LIST.
1. Over the phone
2. Video conference
3. In-person
[WebSearch]
- Show if respondent selected code [8] at B12_ActionTakenBranded.
B13_WebSearch. You mentioned that you searched on the web after seeing the ad for [Insert response from DV_InsertBrandName].
What type of information did you search for?
RANDOMIZE LIST.
RANDOMIZE WITHIN.
1. How the medication works
2. What medications Steglujan is made of Show if respondent is in any of these iterations [1-
5, 17-18].
3. How to take the medication
4. How much the medication costs
5. Information about the side effects of the medication
6. The manufacturer of the medication
7. Other patients’ experience taking the medication
8. Ways to save
9. Other information about the medication
RANDOMIZE WITHIN.
10. The symptoms of Type 2 Diabetes
11. Treatment options for Type 2 Diabetes
12. The causes of Type 2 Diabetes
13. General information about Type 2 Diabetes
14. Other medications that treat Type 2 Diabetes ANCHOR.
97. Something else ANCHOR.

[DiscussedBrand]
- Show if respondent selected any codes [1-3] at B12_ActionTakenBranded.
B14_DiscussedBrand. You mentioned that you spoke to your doctor after seeing this [Insert response from DV_InsertBrandName] ad.
What was the result of your discussion with your doctor?
DEFAULT ORDER.
1. My doctor wrote me a prescription for [Insert response
from DV_InsertBrandName]
2. My doctor gave me [Insert response from
DV_InsertBrandName] samples
3. My doctor gave me both samples and a prescription for
[Insert response from DV_InsertBrandName]
4. My doctor gave me samples for and/or wrote me a
prescription for another medication instead of [Insert
response from DV_InsertBrandName]
5. No changes, I continue to take the same medication
[PrescribeInstead]
- Show if respondent selected code [4] at B14_DiscussedBrand.
- Programmer Comment: Show all brands punched at DV_BrandsAware BUT DO NOT SHOW Brand of Current Loop Iteration
- Answer by column.
B15_PrescribeInstead. What medication did your doctor give samples and/or write you a prescription for instead?
COLS: DEFAULT ORDER. Prescriptio

ROWS: DEFAULT ORDER. Samples n
1 2
sitagliptin)
2. Steglatro (ertugliflozin) 1 2
3. Rybelsus (semaglutide) 1 2
4. Jardiance
1 2
(empagliflozin)
5. Farxiga (dapagliflozin) 1 2
6. Ozempic (semaglutide) 1 2
1 2
+ linagliptin)
1 2
+ metformin)
9. Invokana (canagliflozin) 1 2
1 2
metformin)
11. Janumet XR
1 2
12. Januvia (sitagliptin) 1 2
1 2
+ metformin)
14. Kombiglyze XR
1 2
1 2
saxagliptin)
16. Segluromet
(ertugliflozin + metformin 1 2
hydrochloride)
17. Synjardy
1 2
(empagliflozin + metformin)
18. Xigduo (dapagliflozin+
1 2
metformin)
19. Tradjenta (linagliptin) 1 2
20. Toujeo (insulin
1 2
glargine)
1 2
degludec)
22. Trulicity (dulaglutide) 1 2
23. Victoza (liraglutide) 1 2
24. Trijardy XR
(empagliflozin + linagliptin 1 2
99. None of the above 1 2

[DV_B16QuestionText]
DV_B16QuestionText. DV to capture appropriate question text for B16
DEFAULT ORDER.
1. This ad is for [Insert response from Autocode if respondent selected any codes [2, 98]
DV_InsertBrandName]. How likely are you to talk to your at B7_P3M_AdAware.
doctor about [Insert response from
DV_InsertBrandName] in the future, as a result of seeing
this ad?
2. How likely are you to talk to your doctor about [Insert Autocode if respondent selected code [1] at
response from DV_InsertBrandName] in the future, as B7_P3M_AdAware.
a result of seeing this ad?
[LikelihoodTalkDoctor]
- Show to all.
B16_LikelihoodTalkDoctor. [Insert response from DV_B16QuestionText]
DEFAULT ORDER.
1. Not at all likely
2. Not too likely
3. Somewhat likely
4. Very likely
5. Definitely will PC: Autocode if stub [1, 2 or 3] is selected at
B12_ActionTakenBranded
Loop End - AdRecall_Diagnostics
[DV_P3MAdAware]
DV_P3MAdAware. Capture ads seen in P3M at B7
DEFAULT ORDER.
1. Steglujan TV Ad People Autocode if respondent selected code [1] at
B7_P3M_AdAware for any Iteration(s) [1].
2. Steglujan Web Ad 2 Autocode if respondent selected code [1] at
3. Steglujan Web Ad 1 - Savings Autocode if respondent selected code [1] at
17. Steglujan Web Ad 3 - Fill In Question Autocode if respondent selected code [1] at
18. Steglujan Web Ad 4 - Neon Savings Autocode if respondent selected code [1] at
4. Steglujan FB Ad 1 - Neon Savings Autocode if respondent selected code [1] at
5. Steglujan FB Ad 2 - Silhouette Autocode if respondent selected code [1] at
7. Steglatro Web Ad - Hands Autocode if respondent selected code [1] at
9. Ozempic TV Ad Autocode if respondent selected code [1] at
11. Rybelsus TV Ad Autocode if respondent selected code [1] at
12. Jardiance TV Ad Autocode if respondent selected code [1] at
14. Farxiga TV Ad Autocode if respondent selected code [1] at
15. Trulicity TV Ad Autocode if respondent selected code [1] at
99. Not aware of any ads Autocode if respondent did NOT select codes [1-5,
9, 11-12, 14-15, 17-18] at DV_P3MAdAware.

[UnbrandedAd_Intro]
- Show to all.
- Programmer Comment: Suppress July'20 onward
DT_UnbrandedAd_Intro. Now, we will show you small set of different advertisements. Please answer the following questions keeping in
mind only the ad that is shown.
Please do not think of other advertisements for the same brand or similar advertisements for other brands that
you may have seen.
[DV_UnbrandedAdEligible]
DV_UnbrandedAdEligible. Captures all unbranded ads
DEFAULT ORDER.
1. Unbranded Video_Cat
2. Unbranded Video_Dog
3. Unbranded Video_Expressions
4. Unbranded Video_Hiker
5. Unbranded Video_Marmot
6. Unbranded Video_Seal
7. Unbranded Video_Squirrel
[DV_UnbrandedAdAssigned]
DV_UnbrandedAdAssigned. Assigner
Eligibility variable: DV_UnbrandedAdEligible

If less than 1 category is assigned: Terminate
Step 1:
Step 2:
Programmer Comment: If a stub is a assigned in step 1, the same stub shouldn't be assigned in step 2 (i.e., a respondent should not be
assigned the SAME ad twice).
Loop Start - UnbrandedAdRecall_Diagnostics

[UnbrandedAdRecall_Diagnostics]
- Programmer Comment: Ad Stimuli found here: P:\202_Tischler\202-191284 Merck Steglujan 2020 Consumer Tracking\2_Project
Design\Questionnaire\Exhibits & Stimuli\Ad Stimuli\For Programming\Unbranded Steglatro Ads
Suppress July'20 onward
UnbrandedAdRecall_Diagnostics. UnbrandedAdRecall_Diagnostics
Iterations:
DEFAULT ORDER.
1. Unbranded Video_Cat
2. Unbranded Video_Dog
3. Unbranded Video_Expressions
4. Unbranded Video_Hiker
5. Unbranded Video_Marmot
6. Unbranded Video_Seal
7. Unbranded Video_Squirrel
Questions:
[P3M_UnbrandedAdAware]
- Show to all.

B17_P3M_UnbrandedAdAware. Have you seen this specific advertisement in the past 3 months or so?
DEFAULT ORDER.
1. Yes
2. No
3. Not sure
[UnbrandedAdClick]
- Show if respondent selected code [1] at B17_P3M_UnbrandedAdAware.

B18_UnbrandedAdClick. When you saw this ad, did you click on the link from the ad to get more information?
DEFAULT ORDER.
1. Yes
2. No
98. I don't remember

[UnbrandedAssociation]
- Show if respondent selected code [1] at B17_P3M_UnbrandedAdAware AND respondent selected code [1] at
B18_UnbrandedAdClick.

B19_UnbrandedAssociation. Which medication was featured on the website?

RANDOMIZE LIST.
97. Other ANCHOR.
98. I cannot recall which specific medication this ad is for ANCHOR. EXCLUSIVE.
[DV_UnbrandedAd_ID]
- Hidden Question. Applies if respondent selected code [1] at B17_P3M_UnbrandedAdAware AND respondent selected code [1] at
B18_UnbrandedAdClick.
DV_UnbrandedAd_ID. Capture if respondents identify Steglatro brand from unbranded ads in B18.
DEFAULT ORDER.
1. Correctly Identified Autocode if respondent selected code [2] at
B19_UnbrandedAssociation.
2. Incorrectly Identified Autocode if respondent did NOT select code [1] at
DV_UnbrandedAd_ID.
Loop End - UnbrandedAdRecall_Diagnostics
[DV_P3MUnbrandedAdAware]
DV_P3MUnbrandedAdAware. Capture unbranded ads seen in P3M at B17
DEFAULT ORDER.
1. Unbranded Video_Cat Autocode if respondent selected code [1] at
B17_P3M_UnbrandedAdAware for any Iteration(s)
[1].
2. Unbranded Video_Dog Autocode if respondent selected code [1] at
[2].
3. Unbranded Video_Expressions Autocode if respondent selected code [1] at
[3].
4. Unbranded Video_Hiker Autocode if respondent selected code [1] at
[4].
5. Unbranded Video_Marmot Autocode if respondent selected code [1] at
[5].
6. Unbranded Video_Seal Autocode if respondent selected code [1] at
[6].
7. Unbranded Video_Squirrel Autocode if respondent selected code [1] at
[7].
99. Not aware of any unbranded ads Autocode if respondent did NOT select codes [1-7]
at DV_P3MUnbrandedAdAware.

DIGITAL IQ
[DigitalIQ_Intro]
- Show to all.
DT_DigitalIQ_Intro. We will now ask you some questions about your attitudes, behaviors and feelings about online/digital technology in
your PERSONAL LIFE (not work or job-related).
Please try to exclude your WORK OR JOB LIFE (anything you do for work). We appreciate your attention to detail
and honesty as you answer these questions.
[DigitalActivity]
- Show to all.
C1_DigitalActivity. Which of the following devices have you used for online/digital activity in the last month?
RANDOMIZE LIST.
1. Desktop computer
2. Laptop computer
3. Smartphone
4. Tablet (iPad, Kindle Fire, Surface, Galaxy Tab, etc.)
5. Smart home device (Amazon Echo (Alexa), Google
Home, etc.)
6. Wearable technology (Apple Watch, Samsung Gear,
Fitbit, Garmin, etc.)
[Activites]
- Show to all.
C2_Activites. Which of these online activities have you done in the past week?
RANDOMIZE LIST.
1. Using social media (i.e., Facebook, Twitter, Snapchat,
Instagram, etc.)
2. Streaming video
[SocialMediaPlatforms]
- Show if respondent selected code [1] at C2_Activites.
C3_SocialMediaPlatforms. How often do you use social media platforms to stay in touch with what your friends/family are doing?
DEFAULT ORDER.
1. Multiple times per day
2. About once a day
3. Several times a week
4. A few times a week
5. About once a week or less
6. Never - don't use it
[AccessingInternet]
- Show to all.
C4_AccessingInternet. Do you do any of these things when accessing the internet?
RANDOMIZE LIST.
1. Lead a discussion board or chat group
2. Use Bluetooth to connect other technology to your
devices

[TabletUse]
- Show if respondent selected code [4] at C1_DigitalActivity.
C5_TabletUse. When using your TABLET for online activities like shopping, search, social media, uploading photos/videos, etc., how
would you rate yourself?
DEFAULT ORDER.
1. Learner (just starting to do these activities)
2. Basic (can perform simple functions myself, need help for
other things)
3. Proficient (can perform most functions myself, but
encounter problems sometimes)
4. Advanced (can perform most anything, and when
problems arise I can usually fix them myself)
[SmartphoneSkill]
- Show if respondent selected code [3] at C1_DigitalActivity.
C6_SmartphoneSkill How would you rate your skill level using your smartphone compared to others who are about the same age as
. you?
DEFAULT ORDER.
1. 1 - Much worse Show if respondent selected code [1] at
S15_SegmentQ4.
2. 2 Show if respondent selected code [2] at
S15_SegmentQ4.
S15_SegmentQ4.
4. 4 - About the same Show if respondent selected code [4] at
S15_SegmentQ4.
S15_SegmentQ4.
S15_SegmentQ4.
7. 7 - Much better Show if respondent selected code [7] at
S15_SegmentQ4.
[KnowHowTo]
- Show if respondent selected any codes [1-4] at C1_DigitalActivity.
C7_KnowHowTo. Do you know how to do each of the following without help from anyone else?

ROWS: RANDOMIZE LIST. Yes No Unsure
1. Take a screenshot on a
1 2 3 Show if respondent selected any codes [3-4] at C1_DigitalActivity.
smartphone or tablet
2. Use keyboard shortcuts
on a desktop/laptop
1 2 3 Show if respondent selected any codes [1-2] at C1_DigitalActivity.
(instead of the
mouse/pointer)
[CloudConfidence]
- Show to all.
C8_CloudConfidence. How confident would you be if you were asked to explain what the “cloud” is?
DEFAULT ORDER.
1. 1 - Not confident at all
2. 2
3. 3
4. 4 - Somewhat confident
5. 5
6. 6
7. 7 - Completely confident

[PersonalInformation]
- Show to all.
C9_PersonalInformation. How much do you agree or disagree with the statement below?
I am completely comfortable with the extent to which my personal information is online.

DEFAULT ORDER.
1. 1 - Completely disagree
2. 2
3. 3
4. 4 - Neither agree nor disagree
5. 5
6. 6
7. 7 - Completely agree
[TechBipolar]
- Show to all.
C10_TechBipolar. Please select the option that best reflects how well each statement describes you.
RANDOMIZE LIST.
Describes Describes
Describes me me Describes
me much somewhat somewhat me much
more more more more
1. I am excited about the I am concerned about how
possibilities of artificial 1 2 3 4 artificial intelligence may
intelligence impact the world
I stick with a few apps on
2. I try lots of different
1 2 3 4 my phone/ tablet that I
apps on my phone/tablet
know well
3. It would be easy for me It would be hard for me to
to live in a world without 1 2 3 4 live in a world without
digital technology digital technology
4. The pace of change in I am very comfortable with
digital technology is too 1 2 3 4 the pace of change in
fast for me digital technology
When digital technology
5. When digital technology
doesn’t work, I just roll up
doesn’t work, I get 1 2 3 4
my sleeves and figure it
discouraged easily
out
6. When I get a new
When I get a new device, I
device, I am excited to set 1 2 3 4
dread having to set it up
it up
[DV_DigitalIQSegments]
- Programmer Comment: Typing tool: \\cnc-fsh-106p.elrw.com\Projects2019\202_Tischler\202-191108 Merck Januvia 2020 Consumer
Tracking\2_Project Design\Questionnaire\Typing tool\Merck DigitalIQ Typing Tool 20 items v1.1 - 6.15.18.xlsm
Word document: \\cnc-fsh-106p.elrw.com\Projects2019\202_Tischler\202-191108 Merck Januvia 2020 Consumer Tracking\2_Project

Design\Questionnaire\Typing tool\Merck Digital IQ Typing Tool - Questionnaire - 6.15.18.docx
DV_DigitalIQSegments. What Segment does respondent fall under?
DEFAULT ORDER.
1. Segment 1: Nostalgic Ned
2. Segment 2: Basic Betty
3. Segment 3: Average Amy
4. Segment 4: Emerging Emily
5. Segment 5: Avid Allen

DEMOGRAPHICS
[DemoIntro]
- Show to all.
DT_DemoIntro. Thank you for your time so far. We just have a few more questions.
[TypesOfInsurance]
- Show to all.
- Programmer Comment: Flag (1pt) if select 4+ answers from codes 1-97.
D1_TypesOfInsurance. Now, we have a few questions about your health care coverage. What type of health insurance do you currently
have?
DEFAULT ORDER.
RANDOMIZE WITHIN.
1. Health Maintenance Organization (HMO)
2. Preferred Provider Organization (PPO)
3. A health plan purchased through the market exchange
under the Affordable Care Act
4. High Deductible Health Plan (HDHP)
5. Medicare medical coverage (including Medicare part A/B,
Medicare HMO or Medicare Advantage)
6. Medicare Part D Prescription Drug Plan
7. Medicaid
8. Veteran’s or active military healthcare, such as Tricare
DEFAULT ORDER.
97. Other ANCHOR.
98. Not sure ANCHOR. EXCLUSIVE.
99. I do not have any health insurance ANCHOR. EXCLUSIVE.
[MedCoverage]
- Show if respondent did NOT select code [99] at D1_TypesOfInsurance.
D2_MedCoverage. Does your health insurance coverage include your prescription medication?
DEFAULT ORDER.
1. Yes
2. No
98. Not sure
[PhysicianType]
- Show if respondent selected any codes [1-2] at DV_Wave.
- Programmer Comment: Please suppress this question (DO NOT SHOW AT ALL) after March 1st, 2020
D3_PhysicianType. What type of physician do you primarily see to manage your Type 2 Diabetes?
RANDOMIZE LIST.
1. Primary care physician
2. Endocrinologist
97. Other ANCHOR. EXCLUSIVE.
[FillPrescriptions]
D4_FillPrescriptions. Where do you usually fill your Type 2 Diabetes prescription(s)?
RANDOMIZE LIST.
1. Local pharmacy
2. Mail order Pharmacy
3. Internet / online pharmacy
97. Other ANCHOR.

[DV_Num_MedsUsage]
- Programmer Comment: Please do the sum of ALL medications selected at DV_CurrentMedUsage (including "Other").
DV_Num_MedsUsage. Capture sum of T2D medications currently taking from DV_CurrentMedUsage to check answer at D5 and set error
message.
[NumPrescriptions]
- Show to all.
- Programmer Comment: Total prescription medications should be greater than or equal to Type 2 Diabetes medications, if not,
please show error message: "Please include your Type 2 Diabetes medication(s) as a part of your total prescription medication(s)".
Stub 2 number must be >= to number of meds recorded at DV_Num_MedsUsage, otherwise, show error message below the second
box: "Earlier you mentioned currently taking at least [INSERT DV_Num_MedsUsage] Type 2 Diabetes medication(s). Please review
your answer."
If respondent attempts to put 0 for stub 2, show error message: "Earlier you mentioned currently taking at least 1 Type 2 Diabetes
medication. Please review your answer."

D5_NumPrescriptions. How many prescription medication(s) do you currently take in total, and how many of those are for Type 2
Diabetes?
Number of
COLS: DEFAULT ORDER. Prescriptio
ROWS: DEFAULT ORDER. ns
1. Total prescription
[1] PC: Must be >= stub 2
medication(s)
2. Type 2 Diabetes
[1] PC: Must be >= to number of meds selected at DV_CurrentMedUsage
medication(s)
MIN: 1. MAX:
99. INTEGER
NUMERIC
RESPONSE
S.
[MedConvenience]
- Show to all.
D6_MedConvenience. When taking Type 2 Diabetes medications, which of the following do you find more convenient?
RANDOMIZE LIST.
1. Taking an oral pill once a day
2. Having an injection once a week
[AgeDiagnosed]
- Show to all.
- Programmer Comment: Please make the min value 18 and the max value the respondent's current age [DV_Age]
D7_AgeDiagnosed. Approximately how old were you when you were diagnosed with Type 2 Diabetes? If you are unsure, please provide
your best estimate.
[DV_AgeDiagnosedDifference]
DV_AgeDiagnosedDifference. Calculate years since diagnosis: [DV_Age]-[AgeDiagnosed]

[ActivityFrequency]
D8_ActivityFrequency. How often do you exercise or participate in a physical activity (e.g., going on walks, dancing, running, playing
sports, doing yoga, etc.)?
DEFAULT ORDER.
1. Everyday
2. A few days per week
3. Once a week
4. Less than once a week
5. Never
[GroceryNum]
D9_GroceryNum. Around how many supermarkets or grocery stores that offer healthy food options (e.g. fresh fuits and vegetables,
unprocessed foods, organic, low-carb, low-sodium, etc.) are located in your neighbourhood?
DEFAULT ORDER.
1. 1-2
2. 3-4
3. 5+
99. There are no supermarkets or grocery stores that offer
healthy food options in my neighbourhood
[GroceryTransport]
D10_GroceryTransport. How do you typically get to the supermarkets or grocery stores you shop at?
DEFAULT ORDER.
1. By car or motorcycle
2. By public transportation (e.g. train, subway, bus)
3. Walking
4. Riding a bicycle, skateboard, or scooter
99. I don’t personally go to the grocery store
[Income]
- Show to all.
D11_Income. Last year, what was your household’s total income, before taxes?
Select one.
DEFAULT ORDER.
1. Less than $35,000
3. $35,000 to $49,999
4. $50,000 to $74,999
5. $75,000 to $124,999
6. $125,000 to $149,999
7. $150,000 or more
98. Prefer not to answer
[DV_IncomeNets]
DV_IncomeNets. Hidden variable to capture netted income for weighting.
DEFAULT ORDER.
1. Under $35,000 Autocode if respondent selected code [1] at
D11_Income.
2. $35,000 to $49,999 Autocode if respondent selected code [3] at
D11_Income.
3. $50,000 to $74,999 Autocode if respondent selected code [4] at
D11_Income.
4. $75,000 or more Autocode if respondent selected any codes [5-7]
at D11_Income.

5. Prefer not to say Autocode if respondent selected code [98] at
D11_Income.
[Education]
- Show to all.
D12_Education. What is the highest level of education you completed?
DEFAULT ORDER.
1. Less than high school
2. Completed some high school
3. Completed high school
4. Job-specific training program(s) after high school
5. Some college, but no degree
6. College (such as B.A., B.S.)
7. Some graduate school, but no degree
8. Graduate degree (such as MBA, MS, M.D., Ph.D.)
[HispanicOrigin]
- Show if respondent selected code [2] at DV_EthnicityNet.
D13_HispanicOrigin What is your Hispanic origin or descent? If more than one, please select one of the following you most closely identify
. with.
DEFAULT ORDER.
1. Argentina
2. Brazil
3. Chile
4. Colombia
5. Cuba
6. Dominican
7. Ecuador
8. El Salvador
9. Guatemala
10. Honduras
11. Mexico
12. Nicaragua
13. Panama
14. Peru
15. Puerto Rico
16. Venezuela
97. Other (specify)__________
[HHSize]
- Show to all.
D14_HHSize. How many people of any age live in your household, including yourself? This includes adults as well as children.
[Children]
- Show to all.
D15_Children. Do you have children?
DEFAULT ORDER.
1. Yes
2. No

[NumChildren]
- Show if respondent selected code [1] at D15_Children.
- Programmer Comment: The sum of the grid must be at least 1 (cannot enter 0 for all 3 stubs)
Answer for stub "Living at home" must be less than response at D14_HHSize
D16_NumChildren. How many children do you have?
COLS: DEFAULT ORDER. Number of

ROWS: RANDOMIZE LIST. Children
1. Living at home [1] Show if value provided at D14_HHSize is greater than 1.
2. Living with another
[1]
parent or at school
3. Living on their own [1]
MIN: 0. MAX:
10. INTEGER
NUMERIC
RESPONSE
S.
Subsection Start - COVID-19 Custom Section

Programmer Comment: Suppress whole section July'20 onward
[MedBehaviorChange]
- Show to all.
D22_MedBehaviorChange. We understand that the COVID-19 (“Coronavirus”) outbreak has impacted the lives and access to medical
care for many people. To what extent, if any, has the COVID-19 (“Coronavirus”) outbreak impacted how often
you do the following?
Less often
COLS: DEFAULT ORDER. Stopped than Same as
ROWS: RANDOMIZE LIST. entirely before before
1. Visiting the doctor
managing your Type 2 1 2 3
Diabetes
2. Picking up your Type 2
Diabetes prescription
1 2 3
medications at the
pharmacy in-person
[PharmaHomeDelivery]
- Show to all.
D23_PharmaHomeDelivery. Are you planning to start using a pharmacy home delivery services (e.g., Express Scripts) for your Type 2
Diabetes prescription medications, given the COVID-19 (“Coronavirus”) outbreak?
DEFAULT ORDER.
1. I was already considering using home delivery services
prior to the outbreak
2. I was already using home delivery services prior to the
outbreak
3. After the outbreak, I am now considering using home
delivery services
4. After the outbreak, I am now using home delivery
services
5. I have never and still would not consider using home
delivery services
[LikelihoodToSwitch]
- Show to all.
D24_LikelihoodToSwitch. Has the COVID-19 (“Coronavirus”) outbreak and its related events impacted how likely you are to switch your
Type 2 Diabetes prescription medications, if your doctor recommended it?
DEFAULT ORDER.
1. I prefer to maintain my current Type 2 Diabetes
medications
2. I am now somewhat more likely to switch
3. I am now much more likely to switch

[ChangeToMedCare]
- Show to all.
D25_ChangeToMedCare. Do you expect the COVID-19 (“Coronavirus”) outbreak and its related events to impact any of the following for
you, within the next 6 months?
DEFAULT ORDER.
1. Access to health insurance
2. Prescription medication coverage
3. Ability to afford your current co-payments for your Type 2
Diabetes medications
4. No impact to any of the above EXCLUSIVE.
Subsection End - COVID-19 Custom Section
Subsection Start - COVID-19 Behavior Module

Programmer Comment: Suppress whole section July'20 onward
[COVIntro]
- Show to all.
DT_COVIntro. Lastly, we would like to ask you a few questions about whether your daily activities have been affected by current
conditions.
[BehaviorChange]
- Show to all.
- Note to client: Initial question on COVID-19 behavior change. Asked of all markets.
D17_BehaviorChange. Have you changed your behavior in response to COVID-19 (“Coronavirus”)?
DEFAULT ORDER.
1. Yes
2. No
99. Prefer not to say
[ActivityChanges]
- Show if respondent selected code [1] at D17_BehaviorChange.
- Programmer Comment: If "No" to BehaviorChange, autocode all rows as "Same as before". If "Prefer not to say" at
BehaviorChange, autocode all rows as "Prefer not to say".
- Note to client: Global question on individual activity changes.
D19_ActivityChanges. To what extent, if any, has the COVID-19 (“Coronavirus”) outbreak impacted how often you do the following?
Less often More often

COLS: DEFAULT ORDER. Stopped than Same as than Prefer not
ROWS: RANDOMIZE LIST. entirely before before before to say
1. Going out to restaurants
1 2 3 4 99
or entertainment venues
2. Shopping in stores 1 2 3 4 99
3. Shopping online 1 2 3 4 99
4. Taking surveys 1 2 3 4 99
5. Taking public
transportation (e.g., taxis, 1 2 3 4 99
ride sharing apps, bus, etc)
6. Traveling out of town
1 2 3 4 99
(via airplane, car, etc)
7. Buying nonessentials
1 2 3 4 99
(toys, games, clothes, etc)

[BehaviorResume]
- Show if respondent selected code [1] at D17_BehaviorChange.
- Programmer Comment: If "Prefer not to say" at BehaviorChange, autocode as "Prefer not to say".
D20_BehaviorResume. And how soon do you believe you will be back to your typical behavior and activities impacted by COVID-19
(“Coronavirus”)?
DEFAULT ORDER.
1. Within the week
2. Within the month
3. 2-3 months from now
4. More than 3 months from now
[COVIncomeChange]
- Show to all.
- Note to client: Income adjustment question. To be asked of all consumers.
D21_COVIncomeChange. How has the outbreak of COVID-19 ("Coronavirus") impacted your household’s income?
DEFAULT ORDER.
1. Our income has halted and we have nothing to fall back
on
2. Our income has halted, but we have enough saved to get
by for 3 months
3. We have had a significant reduction that will require some
belt tightening
4. Our income has stayed roughly the same
5. We are among the lucky few whose incomes have
increased
Subsection End - COVID-19 Behavior Module

QC FLAGS
Terminate if respondent has accumulated at least 3 points.
Flag Type Apply To Rule Points

Timer Screener 2 Minutes 1
Timer Main + Screener 7 Minutes 1
Timer Question - S16_AttentiveBipolar 14 Seconds 1
Timer Question - S12_SegmentQ1 8 Seconds 1
Programmer Comment Question - DV_BrandsAware 15 or more stubs are selected 1
Timer Question - C10_TechBipolar 12 Seconds 1
Programmer Comment Question - D1_TypesOfInsurance More than 4 stubs are selected 1
from codes 1-97

Questionnaire Outline: Steglujan 2021 Consumer Tracking 201705 December 03, 2021

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Questionnaire Outline: Steglujan 2021 Consumer Tracking 201705 December 03, 2021

Uploaded by

Copyright:

Available Formats

LRW Study Name: Steglujan 2021 Consumer Tracking

LRW Job Number: 201705

Hold CTRL and click on a question to jump there

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 1

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 3

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 4

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 6

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 7

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 8

MIN: 1915. MAX: 2020. INTEGER NUMERIC RESPONSES.

MIN: 0. MAX: 150. INTEGER NUMERIC RESPONSES.

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 9

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 10

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 11

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 12

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 13

if needed example function can be found here: \\cnc-fsh-106p.elrw.com\Projects2019\006_IPS\Questions - Code and

COLS: DEFAULT ORDER.

MIN: 3. MAX: 200.

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 14

Heard the Have used

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 15

Heard the Have used

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 16

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 17

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 18

TERM IMMEDIATELY IF 7 OR MORE STUBS ARE AUTOCODED HERE

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 19

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 20

COLS: DEFAULT ORDER.

Subsection Start - Segmentation Measures

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 21

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 22

Subsection End - Segmentation Measures

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 23

Eligibility variable: DV_Brands_Eligible

Steglujan (ertugliflozin + sitagliptin)

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 24

COLS: RANDOMIZE LIST. [COLUMN

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 25

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 26

Loop Start - BrandRatings

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 27

Loop End - BrandRatings

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 28

COLS: DEFAULT ORDER.

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 29

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 30

COLS: DEFAULT ORDER.

Loop Start - ReasonsSwitch

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 31

Loop End - ReasonsSwitch

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 32

COLS: DEFAULT ORDER. Not very Somewhat

Loop Start - BrandConsiderations

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 33

Loop End - BrandConsiderations

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 34

COLS: DEFAULT ORDER. Not very Somewhat

LRW # 201705 © 2021 LRW. All rights reserved. CONFIDENTIAL. 35

Capture first mention as DV_TopOfMind_Ad.

if needed example function can be found here: \\cnc-fsh-106p.elrw.com\Projects2019\006_IPS\Questions - Code and

COLS: DEFAULT ORDER.